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The incidence of infections caused by methicillin-resistant Staphylococcus 
aureus (MRSA) has increased world-wide over the past 30 years.
A strain that was introduced into Scotland in 1990 via a patient recently 
returned from Lisbon, Portugal had an unusually resistant phenotype. Ninety- 
tliree isolates were selected and investigated by molecular methods. The 
principal method chosen was agarose gel electrophoresis following digestion of 
whole cell genomic DNA with the restriction enzymes Hhal and SauSAL 
These enzymes recognise 4-base DNA sequences and produced an analytical 
window at the top of an agai'ose gel, which allowed the recognition of plasmid 
DNA fragments and partial digest products. The final result of electrophoresis 
by this method was a considerable improvement over previous methods 
employing enzymes that are 6-base cutters.
The strain was studied in parallel with control groups of Staph, aureus 
that consisted of methicillin-sensitive Staph, aureus, sporadic isolates of
I
MRSA and the epidemic strains EMRSA-1, EMRSA-15 and EMRSA-16.
Analysis of the Hhal restriction enzyme fiagmentation patterns (REFP) of the 
“new” strain and control groups by Dice coefficients of similarity validated the 
technique with respect to discrimination; it was demonstrated that REFP’s of 
epidemiologically unrelated MSSA isolates had low Dice coefficient values 
(mean Sd value = 66%) and that REFP’s of known epidemiologically related 
isolates such as EMRSA-15 had high coefficients of similarity (mean Sd value 
= 99%).
,î'î
The technique showed that all isolates of the new strain were clonal in
.origin (mean Sd value = 95%) and in addition, highlighted the existence of a
 —  --------------
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number of clonal variants (subtypes) to the major REFP type. Sixty-eight 
isolates (73%) gave a genomic fingerprint identical to the index case and were 
designated Hhal type HI. Twenty-five isolates were variants of this type and 
were designated type LH2 (7 isolates), LH3 (6 isolates), LHIO (2 isolates) and 
fifteen of the twenty-five were unique variants designated LH4 -  LH9 and 
LHll -  LH14. Nine isolates of another strain, imported from France and 
phenotypically similar to the study strain were shown to be genetically closely 
related to it.
Inter-group matching of REFP’s showed each control group to be 
genetically distinct to each other and to the “new” MRSA strain.
In a collaborative study, this new strain which has been trivially termed 
the “Lisbon strain” was shown to be closely related to the now well 
characterised Iberian clone MRSA. Variants detected using HhaVSauSAl 
typing also showed parallel variation in PFGE.
A small number of genomic variants were also found within the 
EMRSA-1, 15 and 16 control groups, highlighting the capacity of the technique 
to detect minor genetic change.
Restriction enzyme fingerprinting of whole cell genomic DNA using 
the restriction enzymes Hhal and SauSAl proved to be a simple, economic and
highly discriminatoiy method of typing Staph, aureus strains requiring no
.expensive apparatus.
:-ï:
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1.1 The genus Staphylococcus
Bacteria of the genus Staphylococcus are non-motile Gram 
positive cocci 0.5 - 1.5pm in diameter, which may occui' singly, in pairs, in 
short chains, or most often in grape-like clusters. Medically important 
members of the genus are divided by their ability to produce the enzyme 
coagulase, a virulence factor. Staphylococcus aureus is the major coagulase 
positive species found in human infections although Staph intermedius and 
Staph, hyicus are common veterinary pathogens. Currently the genus 
comprises 32 species (Kloos, 1998) which are widespread in nature, and are 
found mainly on skin and mucous membranes of birds and mammals.
Other than Staph, aureus, species of staphylococci frequently 
implicated as the aetiologic agents of human infections include Staph, 
epidermidis, Staph, saprophyticus. Staph, haemolyticus, and Staph, 
lugdunensis.
Staph, aureus may cause a toxaemic disease in which toxins released by 
multiplying organisms are absorbed by the body. These include epidermolytic 
toxins, which give rise to scalded skin syndrome, enterotoxins - found in 
staphylococcal food poisoning, and toxic shock associated toxin (TSST-1) - 
associated with use of tampons. Most commonly however, Staph, aureus gives 
rise to infections which include boils, carbuncles, cellulitis, impetigo, wound 
infection, endocarditis and septicaemia.
Most infections arise from endogenous sources, with the infecting strain 
identical to the organism isolated from the patients nose swabs (Hobbs et al.,
1947, Valentine and Hall-Smith, 1952, Tulloch, 1954). This is especially the 
case when lesions occur on the face as with sycosis barbae or styes (Kay, 
1962).
1,2 Virulence of Staph, aureus
Staphylococcal disease is clinically diverse as illustrated in Figure 1.1.
The outcome of the relationship of Staph aureus with its host is dependent on 
a number of factors including the properties of the particular strain, the site of
infection and the competency of the hosts’ defences. Staph aureus produces a
■'î
wide range of virulence factors which play various roles in the different disease 
processes. Some of these factors are associated with the cell surface such as a 
protein A (Petersen et a l, 1977), fîbronectin binding protein (Wadstrom, 1991) |iand collagen binding protein (Holderbaum et a l, 1987). In addition to cell it
surface proteins, some strains of Staph aureus also produce a range of extra 
cellular virulence factors including five membrane-damaging toxins, six
enterotoxins, epidermolytic toxin, toxic shock syndrome toxin (TSST-1), and a #
-
pyrogenic exotoxin. Exoenzymes which act as virulence factors include 
coagulase, DNAase, staphylokinase, proteases, lipase, hyaluronidase, 
phosphatase and phospholipase (Arbuthnott et a l, 1990, Arvidson, 1983).
Î
Figure 1.1 (From Arbuthnott et a/., 1990)
Staphylococcus aureus: its host / pathogen relationship in man
Toxin-mediated syndromes
Asymptomatic colonisation 
or local infection Associated infections
Release of extracellular
Baeteraeinia 
(asymptomatic / acute)
Metastatic sites of infection
Staphylococcal scalded skin syndrome 
Food poisoning 
?Toxic shock syndrome
Gastrointestinal tract (G.I.T.
Nasopharynx
Urethra
Vagina
Eyes
Skin Skin: carbuncies, furuncies, 
subcutaneous abscesses
Nasopharynx: sinusitis, tonsillitis, 
glanduiar infections
Eyes: deep orbital infection
G.I.T.: food poisoning
Urethra: cystitis, prostatitis
Vagina: cervicitis, salpingitis, 
pelvic infection
Centrai Nervous System: cerebritis, meningitis, brain abscesses
Abdominal organs: abscesses
Bones, joints: 
osteomyelitis, arthritis
Muscle: abscesses
Heart: endocarditis
Lungs: pneumonia
The virulence of MRSA has been the subject of much debate. There 
appear to be two points of view. Most authorities agree that MRSA are 
potentially as pathogenic as methicillin sensitive Staph aureus (MSSA), 
though some believe that MRSA are not as virulent, and cause infection only in 
certain high risk groups (Lacey, 1987) whereas others believe them to be true 
pathogens (French et a l, 1990, Keane and Cafferkey, 1984, Thompson et a l, 
1982, Peacock et a l, 1981). Thompson and colleagues (1982) highlighted 
three studies in which the overall mortality rate of nosocomial outbreaks of 
MRSA infection had been compared to case matched controls of outbreaks of 
MSSA infection (Crossley et a l, 1979a, 1979b, Peacock et a l, 1980, Boyce et 
a l, 1981). All three studies found no significant difference in overall mortality, 
suggesting that MRSA and MSSA are equally virulent.
In the study by French (1990) above, more than 5000 Hong Kong 
MRSA isolates were shown to be equally as virulent as MSSA. Both groups of 
organisms were isolated in similar proportions from sites associated with 
serious infection and sites associated with colonisation indicating an equal 
ability of both groups to produce invasive infection. In patients with hospital 
acquired bacteraemia, mortality rates were found to be similar in both groups of 
organisms when adjusted for clinical factors.
Transfer of genetic information between different strains of MRSA (and 
MSSA) by plasmids, transposons and bacteriophages leads to evolutionary 
changes le. divergence of strains. These changes may result in strains with 
altered virulence potential (Coleman et a l, 1989). Thus, it can also be argued 
that both MRSA and MSSA are heterogeneous with respect to virulence.
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1.3 Development of resistance
Before the antibiotic era severe staphylococcal infection was associated 
with a high mortality. A limited success was achieved with the introduction of 
sulphonamide in the 1930’s but this was short lived, as many strains soon 
became resistant.
In the early 1940’s the mortality rate declined sharply but temporarily 
following the introduction of penicillin into clinical use. However, the 
widespread use of penicillin resulted in the selection of penicillinase-producing 
resistant strains such that by the late 1940’s virtually all nosocomially acquired 
strains were resistant (Barber, 1948). New antimicrobials continued to appear 
during the 1940’s and 50’s including streptomycin, chloramphenicol and 
erythromycin. Strains resistant to all available systemic antibiotics had i:
appeared by the end of the 1950’s. A major breakthrough in anti- 
staphylococcal therapy came in 1960 with the advent of the semi-synthetic 
penicillinase resistant penicillins, methicillin and cloxacillin (BMJ editorial,
1960). Initially, this appeared to provide a solution to the problem of drug 
resistance, however, as with previous antimicrobials, resistant strains were soon 
detected (levons, 1961, Knox, 1961, Cetin and Ang, 1962, Borowski et al.,
1 9 6 4 ) incidence of infection caused by these strains remained low until 
the late 1960’s when invasive infection became more prominent. This increase 
was “controlled” somewhat during the 1970’s by the use of gentamicin for 
severe infection. Gentamicin had been in use for 10 years before the first 
resistant strains were recorded. This resistance was plasmid mediated and 
probably developed as a result of the widespread topical use of the agent in
dermatology where patients shed large numbers of organisms in skin scales, 
aiding the dissemination of resistance in different strains of Staph, aureus 
(Porthouse et a l, 1976, Speller et a l, 1976, Wyatt et a l, 1977, Warren and 
Roberts, 1976). Almost inevitably, infections due to both gentamicin and 
methicillin-resistant Staph, aureus were recorded (Shanson et al 1976, 
Cafferkey et al., 1983, Selkon et al., 1980). Strains resistant to multiple 
antibiotics including methicillin and gentamicin began to appear in Australia 
(Pavillard et a l, 1982) and London (Shanson et a l, 1976). By the late 
seventies, strains of Staph, aureus causing nosocomial infections which were 
resistant to both these antibiotics, had become very difficult to treat. Whereas 
previously, strains of Staph, aureus resistant to methicillin and other p-lactams 
had not caused major problems, these multiply resistant strains have now been 
responsible for numerous endemic and epidemic outbreaks of infection world­
wide. They have also become extremely difficult to control or eradicate and 
pose serious problems for patients and healthcare workers alike and many of 
these infections are effectively treated only with the glycopeptide antibiotic 
vancomycin.
1.4 Prevalence of MRSA infection
The incidence of infections caused by MRSA in the UK throughout the
of detection and the understanding of resistance mechanisms. Infection rates
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1960’s was generally very low. Reports of infection began to rise towards the
,
end of the decade and these may have been due, in part, to improved methods
*throughout Europe around this time were also on the increase. In the USA
however, numbers of infections due to MRSA remained at less than 1% 
(Barrett et a l, 1968, Sabath et a l, 1968), until the early 1970’s when the 
incidence showed a steady increase (Klimek et a l, 1976, Crossley et a l, 1979a, 
Locksley et a l, 1982, Schaefler et a l, 1984). By the middle of the decade the 
number of infections was falling once again both in the USA and Europe 
(Plorde and Sherris, 1974, Rosendal et a l, 1977, Kayser, 1975). Because of the 
general reduction of MRSA infection together with an increasing number of 
effective anti-staphylococcal antibiotics by the end of the seventies, the period 
was later termed as “the decade of complacency” (Shanson, 1981).
MRSA infections have since risen steadily world-wide and many 
questions still remain unanswered, not least why certain strains (epidemic or 
EMRSA) seem to have a remarkable propensity for spreading and causing 
disease whereas others do not.
To date, 16 epidemic MRSA strains (termed EMRSA-1, 2 etc.) have 
been typed and characterised by The National Staphylococcal Reference 
Laboratory at Colindale, London. These strains have been responsible for 
widespread outbreaks of infection in the UK. The first of these epidemic 
strains, EMRSA-1, was responsible for many outbreaks in the London area and 
the same strain has also been shown to be responsible for similar outbreaks in 
Australia (Bradley et a l, 1985, Cookson and Phillips, 1988, Duckworth et al. 
1988). Since the characterisation of EMRSA-1 the prevalence of major 
EMRSA types has changed in the UK. In 1990 and prior to this, EMRSA-1 
was the major type sent by laboratories in England and Wales to the Reference 
Laboratory at Colindale. EMRSA-2 was also seen but to a lesser extent. In
11
contrast to this, by 1995 isolates of EMRSA-1 had declined and the 
predominant strains were now EMRSA-3, EMRSA-15 and EMRSA-16. The 
number of hospitals affected with EMRSA-3 have remained steady since 1993 
whereas numbers of hospitals affected with EMRSA-15 and 16 have been 
rising together, affecting between 80 - 100 hospitals by the middle of 1995 
(CDR weekly, September 1995).
1.5 Epidemiology of MRSA infection
(a) Sources and transmission o f  MRSA
Within the hospital environment there are certain high-risk units in 
which patients are at greater risk of infection. These tend to be critical care 
areas (Thompson et al., 1982) such as ITU and burns units. Patients in these 
areas are more susceptible to infection having had major surgery, traumatic
injury or severe burns (Peacock et a l, 1980, Crossley et a l, 1979a, 1979b, 
Boyce et a l, 1981, Saiaglou et a l, 1980). Factors associated with MRSA 
acquisition include prolonged hospitalisation, long term and previous antibiotic 
therapy (especially multiple antibiotic therapy), and instrumentation.
The most important mechanism for introduction of MRSA into a 
hospital is probably by transfer of a patient who is already colonised or infected 
with MRSA (Peacock et a l, 1980, Price et a l, 1980, Saraglou et a l, 1980). It 
is perhaps for this reason that large tertiary cai'e facilities experience greater 
problems with MRSA than smaller hospitals, providing a mechanism for the 
transfer of epidemic strains of MRSA over great distances. Saraglou et al 
(1980) highlighted the case of a burns patient who was transferred to another
12
hospital 500 miles away. Following this, six patients became colonised with 
the same strain of MRS A, which later developed resistance to gentamicin and 
gave rise to infection in three of the six.
Other than the patients themselves, hospital personnel and the 
environment may be important reservoirs of MRS A (Thompson et a l, 1982), 
and hospital staff working in areas where such strains are a recognised problem 
are frequently screened for MRSA. However, the overall carriage rate by 
hospital personnel is generally low (Saraglou et a l, 1980) and outbreaks of 
MRSA often occur with no obvious link to hospital personnel.
Whereas in otherwise healthy individuals nasal carriage of MS SA is 
common, nasal carriage of MRSA occurs only infrequently (Crossley et al., 
1979b, Klimek et al., 1976). Reasons for low nasal carriage of MRSA are 
unknown but it has been suggested that factors influencing adherence of MS SA 
to nasal epithelia may differ in MRSA (Aly et ah, 1981).
Nasal carnage of small numbers of MRSA may not be important in the 
transmission of MRSA, as normal breathing does not result in widespread 
dispersal of Staph aureus into the atmosphere. Of greater importance is the 
potential for nasal carriage to act as a source for the transient carriage of MRSA 
on the hands of hospital personnel. This route of transmission is well-
documented (Peacock et a l, 1980). Although this is a major route of
transmission it may be interrupted simply by hand washing precautions by staff 
handling MRSA patients (Thompson et a l, 1982).
The role of the third reservoir, the environment, has been more difficult 
to assess, since there have been fewer detailed investigations. Crossley et al
13
(1979b), isolated MRSA from 33 of 145 environmental surfaces during an 
MRSA outbreak in a burns unit. Thompson and co-workers (1982) found 
similar high rates of contamination in a burns unit. Thus environmental 
contamination may be an important factor in maintaining outbreaks in burns 
units. Other areas where environmental contamination may be high include 
deraiatology wards where patients shed large amounts of skin scales.
MRSA although primarily hospital pathogens do cause outbreaks of 
community acquired infection. Intravenous drug abusers are a well- 
documented group who commonly develop MRSA septicaemia and 
endocarditis (Levine et a l, 1982). Saravolatz et a l (1982a, 1982b) list drug 
abuse, serious underlying disease, previous antibiotic therapy or previous 
hospital admission as major factors associated with community acquired 
MRSA. Hospital admission of patients with community acquired infections is 
an important source of nosocomial epidemics.
Although hospital personnel and the environment may be responsible 
for the transmission of MRSA, the ultimate source is usually the infected or 
colonised patient.
(b) Control o f  MRSA
The most important factors in the control of MRSA in the hospital 
environment include awareness of the patient and institution of excellent 
hygiene (e.g. hand washing). Once introduced into the hospital, eradication of 
MRSA has usually proved to be very difficult. In a study of 104 hospital 
outbreaks of MRSA since 1975, Boyce (1981) reported that over 85%
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continued to have problems with nosocomial infection due to these strains. 
Most control programmes involve regular screening of high-risk patients and 
sometimes of staff who have direct patient contact. Although often overlooked 
in many hospitals, hand-washing procedures can be a major factor in control of 
MRSA spread by breaking the chain of transmission. Construction of purpose 
built isolation units to deal with MRSA patients can be a very costly project. A 
more convenient and more cost effective method of isolation of carriers is to 
discharge them as soon as possible.
As a useful control measure Thompson et al (1982) recommended 
specific precautions appropriate for the site of colonisation or infection, i.e. 
patients with colonised or infected wounds in whom direct contact transmission 
was the most likely mode of spread were managed with wound and skin 
precautions. Patients with extensive burns or respiratory infection were 
confined using strict isolation procedures because of the potential for airborne 
transmission. Patients with colonisation or infection of mucosal surfaces or the 
urinaiy tract were managed with strict hand-washing precautions after direct 
contact. These precautions were maintained for the duration of hospitalisation.
In the UK, a combined working party was set up to devise measures for 
the control of epidemic strains of MRSA within the hospital environment. As a 
result, guidelines were drawn up and published in 1986 (Working party report, 
Ayliffe et a l, 1986). Since this date these guidelines have been revised twice 
(Ayliffe et a l, 1990, 1998). In addition the working party also published 
guidelines on control of MRSA in the community (Ayliffe et a l, 1995).
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The working party guidelines highlighted the need for screening of 
patients and of staff in particular situations. For example, on admission a 
patient known to be a cairier or infected with MRSA or a patient admitted from 
another hospital or ward where there is cun’ently MRSA present, should 
initially be admitted to an isolation ward or side room. Screening swabs should 
be taken from sites including nose, throat, perineum, wounds and areas of 
abnormal skin. In addition, patients from abroad should also be screened as 
many other countries have major EMRSA problems. Appropriate measures 
should be taken by staff to prevent spread of MRSA by improving hand­
washing procedures using antiseptic disinfectants or 70% alcohol. Where 
patients or staff are found to be infected with or caiTying MRSA, prompt and 
appropriate measures should be taken. Nasal carriage may sometimes be 
eradicated by treatment with mupirocin ointment three times daily for five days. 
In general systemic therapy to eliminate colonisation is not recommended as 
resistance may develop. Where a member of staff is colonised a short systemic 
course of rifampicin may be considered if the isolate has been shown to be 
susceptible, preferably in combination with another agent such as ciprofloxacin 
or fusidic acid.
In cases of serious clinical infection vancomycin is the prefeiTed option. 
Teicoplanin, another glycopeptide antibiotic may also be effective. Although a 
more expensive option, it is less toxic and easier to administer.
The guidelines also recommended regular sampling of previously 
positive patients. A set of screening swabs as previously mentioned should be
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taken on a weekly basis and thi'ee sets of negative swabs must be obtained 
before the patient be considered clear of MRSA.
Other areas covered by the working party report include implications to 
health care staff and their families infected, or colonised with MRSA, transfer 
of colonised / infected patients within hospital and between other hospitals. 
Finally, the guidelines outline basic microbiological procedures involving 
sampling and processing of screening swabs and characterisation of EMRSA 
strains.
The cost of controlling MRSA can be high although there is general 
agreement that ignoring the problem can be even greater particularly when the 
possibility of litigation from an infected patient is considered. In their Hong 
Kong study, Cheng and French (1988) showed that the average cost of 
antimicrobial therapy per patient with MRSA bacteraemia was £440 compared 
to £60 for patients with MS SA bacteraemia. The greater expense was due to 
more costly antimicrobials and longer treatment.
1.6 Mechanism of methicillin resistance
(a) mecA and mec associated DNA
MRSA contain approximately 30 ~ 50 kb of additional chromosomal 
DNA known as the mec region which is not found in methicillin susceptible 
strains (Beck et al,, 1996). It is located close to the pur-nov-his gene cluster on 
the Smal-G fragment of the NCTC 8325 Staph, aureus chromosome (Pattee et 
al., 1990). Within the mec region is contained mecA, a structural gene for PBP
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2a, a penicillin-binding protein with low affinities to practically all p-lactam 
antibiotics; mecl and mecRl, regulatoiy elements controlling mecA 
transcription; and 20 - 45 kb of mec-associated DNA.
The mec A promoter region, which is the first 300 nucleotides of mec A 
and its regulatory genes mecl and mecR.1, is similar in sequence to the 
staphylococcal (3-lactamase gene (Matsuhashi et ah, 1986; Song et al., 1987). 
Introduction of mec A  confers methicillin resistance on MS SA isolates and 
transposon mutagenesis renders highly resistant Staph, aureus strains 
susceptible to methicillin, therefore the principal role of the mecA gene in 
expression of methicillin resistance has been well established (Matthews and 
Tomasz, 1990; de Lencastre et ah, 1994). As the mec A  gene is found in > 90% 
of clinical MRSA and is absent in MS SA strains, the presence of the mec A  
gene is considered to be the hallmark for identification of MRSA strains and 
many laboratories now use various PCR protocols for the detection of the mec A  
gene (Tokue et al., 1992; Unal et al., 1994). In addition to MRSA, the mec A  
gene is widely distributed among other species of staphylococci but has not 
been found in any other genus of bacteria. At present the origins of mec A  in 
Staph, aureus are uncertain but it may have arisen in a coagulase-negative 
strain, possibly Staph, sciuri (Wu et al., 1996; Wu et al., 1998). It is unknown 
exactly how mec A  was acquired by MRSA but transposition seems likely since 
mec A  contains one or more copies of IS257, inverted repeats at its ends, and 
two open reading frames that may encode recombinases.
Two structurally different types of mec region DNA are known. When 
the mec region DNA of levons’ first reported MRSA from 1961 (NCTÇI0442)
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was compared with a Japanese strain from 1982 (N315), it was found that the 
MRSA from 1961 contained a mec region of about 32kb as opposed to a mec 
region of about 51 kb in the Japanese strain. The mec region from NCTC 10442 
was found to differ from N315 due to (I) absence of the mec regulator gene 
mecl, (2) a truncated version of mecRl and (3) presence of part of a 
presumptive mobile genetic element (Hiramatsu, 1995). These are 
representative of the two distinct types of mec region DNA carried by MRSA 
all over the world. In addition most modern strains of MRSA carry a secondary
insertion of the transposon Tn554 integrated into their mec DNA which 7:
harbours genes for resistance to macrolides, lincosamides and streptogramin B 
(MLS).
Although the two mec regions have a different genetic organisation, the
nucleotide sequences outside the boundaries of these regions are common to
both types indicating that they integrated at exactly the same site of the Staph
aureus chromosome. This is highly suggestive of the acquisition of mec as a
.single primary event and subsequent divergence and modification.
(b) Expression o f  methicillin resistance
%
It is now well known that expression of methicillin resistance in mec A  - 
carrying clinical strains o f Staph aureus is typically heterogeneous and MIC’s
' ■ Irange from susceptible (<16mg/L) to highly resistant (MIC>2000mg/L). Such 
a wide variation in MIC’s indicates that the acquisition of the mec A  gene alone 
is not sufficient to render the cell fully resistant to methicillin. By insertional  ^|
'Iinactivation of genes using the transposon Tn557, Berger-Bachi and co-workers |
highlighted the role of at least six additional aux or fern genes (Berger-Bachi, f
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names were abbreviated fiom auxiliaiy or factors essential for methicillin
Several authors have expressed different views on the evolution of
transmission of the mecA gene, giving rise to a number of unrelated clones 
(Musser and Kapur, 1992).
■ ,
1983; Berger-Bachi et al., 1989; de Lencastre and Tomaz, 1994). These gene li
jÿ:
resistance and include fem A  - E, which are necessary for flill expression of
methicillin resistance. These fern factors are chromosomal genes located 
distantly to mec and have been shown to be present in both resistant and 
susceptible strains. With the exception of femE whose exact function is as yet 
unclear, all fem  factors are involved in peptidoglycan synthesis.
1.7 Strain identification and epidemiological typing of MRSA
MRSA. Some have argued for the evolution of MRSA from a single clone
.suggesting that the acquisition of the mecA gene occurred as a singular event, 
.all later strains being descendants of this original single strain (Lacey and 
Grinstead, 1973; Kreiswirth et al., 1993). Others suggest horizontal
Irrespective of whether mono or polyclonal, MRSA have evolved into a 
heterogeneous group of organisms and it is now necessary to use 
epidemiological typing schemes to identify individual strains responsible for 
outbreaks of infection, to trace the sources and monitor the spread of outbreaks. 
Many of the genetic techniques used to type or “fingerprint” strains of MRSA 
can also yield valuable information about the organisms’ evolution and the 
degree of diversity amongst strains. In the early MRSA encountered by levons, 
Cetin, Knox and others in the early 1960’s, resistance to methicillin,
20
erythromycin (inducible) and streptomycin (high level) was typically 
chromosomal whereas resistance to tetracycline, |3-lactamase and heavy metals 
was plasmid encoded. In contrast, EMRSA encountered today in the UK, 
Australia and Europe contain many more chromosomal resistance determinants 
including p-lactamase, various heavy metals, sulphonamide, trimethoprim, 
fusidic acid, rifampicin and gentamicin.
Epidemiological typing can be both costly and labour intensive, and 
should only be performed with clear objectives in mind. These include the 
determination of the extent of an outbreak of infection, determination of ways 
in which infection is spread and the evaluation of preventative measures and 
monitoring of infection in specific areas where infection is a particular hazard.
Numerous typing schemes for the epidemiological investigation of 
many bacterial species have been developed. Traditional phenotypic methods 
include antibiogram typing (Hartstein et a t 1987, Holmberg et al. 1984, Parisi
1985, Pfaller and Herwaldt, 1988), biotyping (Grimont and Grimont 1978, 
Parisi 1985, Rennie et al. 1978, Granato et al. 1983), serotyping (Crichton and 
Old 1980, Delmer et al. 1986, Poh et al. 1988, Joly et al. 1986) and phage 
typing (Holmberg et al. 1984, Parisi 1985). Molecular phenotypic techniques 
include immuno-blotting (Lee and Burnie 1988, Mulligan et al. 1988, Coia et 
al. 1990) and multi-locus enzyme electrophoresis (MLEE) (Caugant et al.
1986, Selander a/. 1986).
Genotypic teclmiques have evolved due to the advances in molecular 
biology and most utilise differences in nucleotide sequence between the 
organisms’ genomic or extra-clrromosomal DNA. These include the
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determination of plasmid profiles (Schaberg et al. 1981, Holmberg et a l 1984, 
Hartstein et al 1987, Parisi 1985, Coia et a l 1988, Mayer 1988, Poh et al. 
1988) and restriction endonuclease (RE) analysis of plasmid and genomic DNA 
(Mickelsen et al 1985, Parisi 1985, Tenover 1985, Hawkey 1987, Coia et al 
1988, Grothues et al 1988, Mayer 1988, Renaud et al 1988, Jordens and Hall 
1988, Patterson et al. 1989). Newer teclmiques have been developed which 
avoid interpretation of large numbers of fragments. These include pulse-field 
gel electrophoresis (PFGE), (Ichiyama et al. 1991, Prévost et al 1992, 
Struelens et al 1992, Wei and Grubb 1992) and Southern hybridisation 
techniques using a variety of DNA and RNA probes (Kreiswirth et a l 1990, 
Goering and Duensing 1990, Hadom et al. 1990, Schwarzkopf and Karch 
1994).
All typing methods have advantages and disadvantages in any given 
situation dependent upon reasons for typing and the degree of discrimination 
required.
Phenotypic typing methods depend on the expression of markers, for 
example antibiotic resistance or the production of a particular enzyme. A 
major limitation of this approach is that phenotypic markers are not always 
stably expressed (e.g. antibiotic resistance mediated by mobile genetic 
elements) under different cultural or environmental conditions. The genetic 
basis of the phenotypic variability is usually unknown and the observed 
phenotypic variations can often be caused by more than one type of genetic 
event, as is the case with staphylococcal bacteriophage typing (Kreiswirth et 
a/., 1993). Not all phenotypic methods can assign an isolate to a definite type.
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This becomes a limitation when phage typing MRSA, as many strains are non- 
typeable. Another major disadvantage of phenotypic typing methods is that 
they do not demonstrate relationships between types.
In addition, techniques such as phage typing require careful 
standardisation and are therefore generally only performed by reference 
laboratories.
In contrast, systems based on DNA analysis will always place an isolate 
into a “type”, and the techniques are not limited to specific organisms or groups 
of organisms. For each technique the method is virtually identical and uses the 
same reagents with only minor changes regardless of the source of the DNA.
The principle involved in genomic fingerprinting is that the 
chromosome contains regions that are highly conseiwed, (generally containing 
sequences for proteins vital for cell function or sequences for rRNA) and other 
regions in which the DNA is subject to rearrangements and mutations. When a 
mutation occurs in a restriction site the DNA is not cleaved and differences in 
fragment size and number can be demonstrated between isolates with non­
identical chromosomes. The degree of difference between a set of isolates’ 
DNA fingerprints gives an indication as to whether the isolates are related, 
identical or different. Although mutations can occur in highly conserved 
regions of the chromosome these tend to be lethal and are therefore not passed 
on. These differences in fragment sizes between a group of related organisms
are known as restriction Ifagment length polymorphisms or RFLP’s.
Natural mutations occur in bacteria over time and may result in 
formation of RFLP’s within a single strain. It is therefore important to bear this
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in mind when examining isolates recovered from outbreaks spamiing many 
months or years, as is the case with the “Lisbon” strain which has persisted in 
Scotland since its introduction in 1990.
All of the techniques mentioned thus far have been extensively applied 
and evaluated either alone or in various combinations in studying the clinical 
epidemiology of a wide range of organisms causing nosocomial infection. For 
example, Archer and Mayhall (1983) used antibiogram, phage type, 
aminoglycoside inactivating enzymes and plasmid profiles to trace an outbreak 
of nosocomial MRSA infection. They found 17 patients, 12 environmental 
sites and three hospital personnel to be infected or colonised with the epidemic 
strain. The outbreak strain was rifampicin resistant and all indigenous strains 
were sensitive to rifampicin thus making the antibiogram a very useful marker 
with which to initially screen large numbers of specimens. They found phage 
typing to be poorly reproducible within local laboratories and results too slow 
to be of any immediate epidemiological value. These findings were consistent 
with the general view that phage typing of staphylococci is a skilled technique, 
requires specialist knowledge and expertise, does not always provide 
discrimination and as such is best performed by reference centres. Plasmid 
pattern analysis revealed all isolates of the epidemic strain to contain tliree 
plasmids of 34, 1.8, and 1.5 megadaltons. No other strains examined exhibited 
this profile. They concluded that plasmid analysis was of greatest value in this 
study and recommended its use in future epidemiological investigations.
Coia et al. (1990) used the greater discriminatory powers of restriction 
enzyme fingerprinting of plasmid DNA in conjunction with simple biotyping,
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phage typing and immunoblotting of exported proteins to characterise a 
collection of 45 MRSA isolates from Glasgow Royal Infirmary between 1985 - 
1986. Using Hae 111 to digest the plasmid DNA they were able to group 43 of 
the 45 isolates into two major groups that correlated strongly with the two 
major immunoblot groups found. The techniques used were able to provide a 
breadth of epidemiological infoiTnation, confirming the existence of two major 
clones within the hospital, which however was evident from antibiogiam and 
biotype analysis.
In a multi-institutional study to determine the strengths and weaknesses 
of 12 epidemiological typing systems, Tenover and co-workers (1994) 
compared traditional methods such as phage typing, biotyping and antibiogram 
typing with more modern molecular typing including RFLP typing with gene 
probes, IS probe typing, FIGE, PFGE, immunoblotting, MLEE, restriction 
enzyme (RE) analysis of PCR products (coagulase genes), ribotyping and RE 
analysis of plasmid DNA. Although the molecular techniques were highly 
successful in identifying the outbreak strains, as stated previously they are for 
the most part difficult to perform, expensive and require a considerable amount 
of expertise in the interpretation of results. Overall, no single method was 
found to be obviously superior and as other workers have also found (Parisi, 
1985) a carefully selected combination of techniques dependent on the 
organism to be typed is often the most useful approach to epidemiological 
typing.
With the range of typing techniques now available, a very detailed 
picture of the epidemiology of infectious agents is often possible allowing
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identification of individual strains or clones to be made and their relationships 
with other strains and clones of an individual species to be ascertained.
1.8 MRSA in the West of Scotland
Outbreaks of infection due to epidemic strains of methicillin-resistant I
Staph, aureus have been well documented in other parts of the UK, however in 
Scotland less MRSA data has been published and the picture has been less 
clear. Figures obtained fi'om the Scottish Centre for Infection and 
Environmental Health (SCIEH) suggest that prior to 1990 there were relatively 
few reports of MRSA, and of these the majority were from Greater Glasgow 
Health Board (Figures 1.2 and 1.3). In 1991 there was a sudden increase in 
notifications which corresponded to the arrival of the Lisbon strain in Glasgow.
Following this increase the numbers remained steady until 1995 after which 
numbers rose sharply to more than 4000 in 1997 and this figuie is still rising in 
1998. The sudden increase in MRSA from 1995 onward represented the arrival 
in Scotland of EMRSA-15 and 16.
Preliminary phenotyping (simple biotyping, antibiogram and phage 
typing) of MRSA strains sent fi'om laboratories in the West of Scotland to Dr 
Dugald Baird at Glasgow Royal Infirmaiy led to recognition of an unusual 
strain of MRSA. The strain was urease positive, Tween 80 hydrolysis negative, 
resistant by disc diffusion test to erytliromycin, clindamycin, tetracycline, 
ciprofloxacin, rifampicin and all aminoglycosides in addition to (3-lactam 
antibiotics. It was sensitive to trimethoprim, fusidic acid, mupirocin and
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chloramphenicol. Most strains were phage type 29/77/84/85 or 54/77/84/85. A 
few strains were untypable by phage.
27
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Subsequent investigations suggested that the earliest recognisable 
isolate in Scotland had been obtained in late 1990 from a patient admitted to 
Gartnavel General Hospital in Glasgow, from Lisbon, Portugal. Soon after this 
initial isolation the strain was also detected in the nearby Glasgow Western 
Infirmary, and over the next few years it was isolated from patients in most 
acute hospitals in the West of Scotland. It resulted in a wide range of 
staphylococcal infections as well as much colonisation and it produced 
infection control problems similar to those seen in England with other epidemic 
MRSA strains. The strain was referred to locally as the “ Lisbon” strain.
1,9 Aims of the investigation and study design
(a) Aims o f the investigation
The aims of the investigation were as follows:
1. To establish whether epidemiologically unrelated isolates of
MRSA were diverse on the basis of Hhal and SauSAl REFP’s.
2. To assess the diversity of Staph aureus from different
epidemiological groups.
-y
3. To determine whether those isolates phenotypically similar and
designated the Lisbon strain were genotypically consistent with the 
expansion of a single clone.
4. To determine whether Hhal REFP’s were sufficiently
discriminating to allow recognition of variants.
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6. To determine whether this strain was closely related to other 
MRSA, EMRSA or MSSA
By examination of any REFP’s produced following digestion and 
fragment separation in agarose gels, it was hoped to gain an insight into the 
strains’ evolution since its first appearance in the West of Scotland, and by 
study of all of the data generated, gain a greater understanding of the 
epidemiology of infections caused by “Lisbon strain” MRSA.
(b) Techniques used to characterise the “Lisbon strain”
The isolates investigated in this study comprised a representative 
number (93) of Lisbon strain MRSA from a collection gathered by Dr D.R. 
Baird. Temporally, the isolates spanned a period from 1990 to 1995. The 
sources of the isolates covered an area that encompassed five Health Boards. 
Prior to their inelusion in the study, extensive phenotyping of the isolates was 
carried out at Glasgow Royal Infirmaiy and Hairmyres Hospitals with phage 
typing being performed initially at Gartnavel Hospital and latterly at the 
Victoria Infirmaiy, Glasgow. The isolates were tested by disc diffusion method 
for sensitivity to penicillin, methicillin, erythromycin, clindamycin, neomycin, 
kanamycin, streptomycin, gentamicin, netilmicin amikacin, tetracycline, 
sulphonamide, trimethoprim, fusidic acid, chloramphenicol, rifampicin, 
vancomycin, mupirocin and ciprofloxacin. Tests performed to obtain a simple 
biotype included Tween 80 hydrolysis, ui'ease production, tube coagulase, latex 
slide coagulase (Staphaurex"^^, Murex diagnostics Ltd.), latex / RBC
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To evaluate the usefulness of this technique with the chosen enzymes 
for detecting RFLP’s, the genetic relatedness of “Lisbon” MRSA to other 
MRSA (OMRSA) strains and to MSSA strains from a variety of sources was 
also examined. If the restriction enzyme fragmentation patterns (REFP) of
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haemagglutination slide coagulase (Slidex™, Biomerieux) and DNase 
production in agar (Oxoid, Unipath) following overnight incubation.
The results of initial phenotypic typing had shown all isolates to be 
closely related. Isolates that conformed to the “Lisbon” strain phenotype were 
included in the study, namely, rifampicin resistant, aminoglycoside resistant, 
urease positive and Tween 80 negative. All phenotypic tests were repeated as 
part of the study.
.On the basis that genotypie typing can provide a greater degree of
discrimination and can give insights into the evolution and divergence of clonal 
populations, a molecular approach was undertaken to study these isolates using 
RE analysis of genomic DNA. The restriction enzymes used for this analysis 
were the four-base cutters Hhal (recognition site: GCG' C) and Sau3Al 
('GATC), as opposed to the six-base cutters used by other authors (Jordens 
and Hall, 1988; Hall et al., 1989; Matthews et al., 1992). The four base cutters 
result in a number of large DNA fragments (approximately 4-20kb) which can 
be clearly resolved on an agai'ose gel.
A number of restriction enzymes had been screened previously for their 
suitability to type Staph, aureus and on this basis Hhal and SauSAl were 
selected for use in this study (D. Platt, personal communication).
. îvf
“Lisbon strain” isolates appeared similar to uni-elated strains, then the inference 
was that the region of the genome optimally separated by a particular RE under 
specific gel running conditions was too highly conserved and therefore the 
technique as an epidemiological typing tool was not discriminatory enough 
when used with these enzymes. Restriction enzyme analysis of plasmid DNA 
using the same enzyme was also performed on selected isolates in order to 
ascertain to what degree plasmid DNA contributed to these REFP’s or indeed 
the overall genomic fingerprint.
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2.1 Collection of isolates
(a) Lisbon isolates
One hundred isolates of MRSA previously categorised as Lisbon strains 
on the basis of phenotypic typing methods (Table 2.1) were obtained from the 
collection of Dr. D. Baird at Hairmyres Hospital in East Kilbride for inclusion 
in the study. All isolates were subcultured to horse blood agar to confirm 
purity and identity as Staph, aureus isolates by Gram stain and Slidex test 
(Biomerieux).
The Lisbon isolates were originally isolated from a wide area of the 
West of Scotland; from Dumfries in the south-west to Oban in the north-west 
and included both community and hospital acquired isolates. The majority of 
these isolates were collected between October 1992 and October 1993, 
although a number of early isolates from the Western Infirmaiy in Glasgow 
(1990) were also included, as were some later isolates of the strain from 1995.
They represented isolates from a wide range of clinical conditions; from 
nasal carriage and colonisation through localised infection to septicaemia.
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Table 2.1
Phenotypic characteristics of Lisbon strain MRSA
Tween 80 
Hydrolysis
Urease Staphaurex Phage type Resistant to
NEGATIVE POSITIVE MOSTLY NEGATIVE 54/77/84/85 MET,ER,CD ■'1Î
(60%) 29/77/84/85 TET.CIP,RIF 1AMINO
SU
MET: methicillin, ER; erythromycin, CD; clindamycin, TET: tetracycline, GIF: ciprofloxacin 
RIF: rifampicin, AMINO: all classes o f aminoglycosides, SU: sulphamethoxazole
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(b) Control groups
A  number of control groups were included in the study to enable 
comparisons to be made between the Lisbon strain and other groups of both 
related and unrelated strains of Staph aureus. This included isolates of 
epidemiologically unrelated MSSA. These were included in order to show that 
the enzymes chosen had sufficient resolving power to type known unrelated 
isolates as different strains and in so doing obtain an estimate of the expected 
breadth of diversity among unielated isolates of the same species. Isolates of 
EMRSA (EMRSA-1, 15 and 16) were included to determine the sensitivity of 
the typing systems in identifying them as belonging to these types. Isolates of 
sporadic MRSA were included in order to determine relationships (if any) 
between these and the other MRSA clonal groups. Each of these MRSA 
groups was also chosen to provide some insight to the diversity of MRSA when 
compared within their groups, between the groups and with MSSA.
A strain of Staph hyicus was also included to illustrate the genetic 
distance between different strains of Staph aureus and a different species of 
coagulase positive Staphylococcus and to provide an outlier for the 
construction of an evolutionaiy tree (Saitou and Nei, 1987).
These strains were collected from various sources as shown in Table 
2.2, and their identity was confirmed as described above.
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2.2 Storage of isolates
Three to four well isolated colonies from each isolate grown in air 
overnight at 37°C on Columbia horse blood agar were inoculated into a 
Protecf^'^ vial (Technical Service Consultants) as per manufacturer’s 
instructions and stored at -70°C. When required, isolates were revived from 
Protect''’'^  by sub culture of a bead onto horse blood agar. Each isolate was 
kept on this medium at 4°C for short-term maintenance prior to all tests.
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2.3 Antimicrobial susceptibility testing
Susceptibility tests were performed by disc diffusion on lysed blood 
DST agar (Stokes and Ridgway, 1980) against the following agents: methicillin 
5|ug (MET), penicillin lU (PEN), erythromycin 5pg (ERY), clindamycin lOpg 
(CD), fusidic acid lOpg (FUS), ciprofloxacin Ipg (CIP), mupirocin 5pg 
(MUP), tetracycline lOpg (TET), chloramphenicol lOpg (CM), rifampicin 2pg 
(RIF), sulphamethoxazole 25pg (SU), trimethoprim 1.25pg (TM), neomycin 
lOpg (NM), kanamycin 30pg (KM), streptomycin lOjag (SM), gentamicin 
lOjig (CM), netilmicinlOjug (NET), and amikacin 30qg (AK).
i
T able 2.2
Origin of isolates selected for study
STRAIN No. STUDY TYPE HOSPITAL SITE DATE
AB 01 LISBON CLYDEBANK HEALTH CENTRE PUS 09-NOV-92
A3 02 LISBON n k ‘ NK NK
A3 03 LISBON NK NK NK
A3 04 LISBON NK NK NK
A3 05 LISBON 3ALLOCHMYLE HOSPITAL GROIN WOUND 23-OCI-92
A3 06 LISBON BALLOCHMYLE HOSPITAL SPUTUM 22-JuI-93
A3 07 LISBON CROSSHOUSE HOSPITAL HIP WOUND 11-May-93
A3 08 LISBON CROSSHOUSE HOSPITAL PERINEUM I7-May-93
A3 09 LISBON CROSSHOUSE HOSPITAL EYE 26-May-93
A3 10 LISBON CROSSHOUSE HOSPITAL PERINEUM 3 1-May-93
A3 11 LISBON CROSSHOUSE HOSPITAL HIP WOUND 3 1-May-93
A3 12 LISBON CROSSHOUSE HOSPITAL NASAL 01-Jun-93
A 3 13 LISBON CROSSHOUSE HOSPITAL VARICOSE ULCER 3 1 -May-93
A3 14 LISBON LARGS HEALTH CENTRE VARICOSE ULCER 03-Jun-93
A3 15 LISBON CROSSHOUSE HOSPITAL CENTRAL LINE EXIT NK
A3 16 LISBON CROSSHOUSE HOSPITAL NK NK
A3 17 LISBON CROSSHOUSE HOSPITAL NK NK
A3 18 LISBON CROSSHOUSE HOSPITAL NK
A3 19 LISBON DUMFRIES ROYAL INFIRMARY NK
A3 20 LISBON DUMFRIES ROYAL INFIRMARY NK
A3 21 LISBON GLASGOW ROYAL INFIRMARY GASTROSTOMY 17-NOV-93
A3 22 LISBON GLASGOW ROYAL INFIRMARY WOUND DRAIN IO-Mar-93
A3 23 LISBON GLASGOW ROYAL INFIRMARY ABDOMEN WOUND 11-May-93
A3 24 LISBON GLASGOW ROYAL INFIRMARY BREAST ULCER 27-May-93
A3 25 LISBON GLASGOW ROYAL INFIRMARY URINE 07-Jiin-93
A3 26 LISBON GLASGOW ROYAL INFIRMARY URINE 12-Jul-93
A3 27 LISBON GLASGOW ROYAL INFIRMARY EYE 26-JiiI-93
A3 28 LISBON GLASGOW ROYAL INFIRMARY URINE 26-Jut-93
A3 29 LISBON GLASGOW ROYAL INFIRMARY BLOOD 02-Aug-95
A3 30 LISBON GLASGOW ROYAL INFIRMARY URINE 01-Aug-93
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T able 2.2 Cont.
STRAIN No. STUDY TYPE HOSPITAL SITE DATE
AB31 LISBON GLASGOW ROYAL INFIItMARY ABDOMEN DRAIN 11 -Aug-93
AB 32 LISBON GLASGOW ROYAL INFIRMARY URINE I2-Sep-92
AB 33 LISBON GLASGOW ROYAL INFIRMARY NK 26-NOV-92
AB34 LISBON GLASGOW ROYAL INFIRMARY BLOOD I4-Feb-93
AB35 LISBON INVERCLYDE HOSPITAL URINE
AB 36 LISBON INVERCLYDE HOSPITAL NK
AB37 LISBON LAW HOSPITAL URINE 05-Nov-92
AB38 LISBON LIGHTBURN HOSPITAL EYE 15-Dec-92
AB39 LISBON CUMBERNAULD HEALTH CENTRE WOUND 05-May-93
AB 40 LISBON HAMILTON HEALTH CENTRE ABDOMEN WOUND 2 1-Jul-93
AB41 LISBON MONKLANDS HOSPITAL WOUND I4-Sep-93
AB42 LISBON ROYAL ALEXANDRIA HOSPITAL GROIN 09-Aug-93
AB43 LISBON ROYAL ALEXANDRIA HOSPITAL WOUND 21-Sep-93
AB 44 LISBON BARRHEAD HEALTH CENTRE WOUND 2 1-Sep-93
AB45 LISBON ALEXANDRA HEALTH CENTRE FOOT ULCER 04-May-93
AB46 LISBON VALE OF LEVEN HOSPITAL TRACHEOSTOMY 07-May-93
A8 47 LISBON VALE OF LEVEN HOSPH AL URINE lO-May-93
AB48 LISBON VALE OF LEVEN HOSPITAL WOUND DRAIN 09-Jul-93
AB49 LISBON VALE OF LEVEN HOSPITAL GROIN 16-Aug-93
AB 50 LISBON VALE OF LEVEN HOSPITAL NK
AB51 LISBON HELENSBURGH HEALTH CENTRE WOUND 06-Aug-93
AB 52 LISBON STOBHILL HOSPITAL PERM CATHETER 03-Aug-93
AB53 LISBON STOBHILL HOSPITAL STUMP WOUND 29-Sep-93
AB 54 LISBON STOBHILL HOSPITAL BLOOD 29-Sep-93
AB 55 LISBON GLASGOW ROYAL INFIRMARY PENIS 07-Nov-94
AB 56 LISBON GLASGOW ROYAL INFIRMARY PERISPLENIC ABSCESS I9-JuI-94
AB 57 LISBON GLASGOW ROYAL INFIRMARY NEPHROSTOMY URINE 06-Jui-94
AB58 LISBON STOBHILL HOSPITAL WOUND 23-Aug-93
AB59 LISBON GLASGOW WESTERN INFIRMARY BLOOD 01-Dec-90
AB60 LISBON CROSSHOUSE HOSPITAL SKIN 05-Feb-91
AB61 LISBON CROSSHOUSE HOSPITAL SPUTUM 04-Mar-91
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Table 2.2 Cont.
STRAIN No. STUDY TYPE HOSPITAL SITE DATE
AB 62 LISBON GLASGOW ROYAL INFIRMARY CATHETER EXIT SITE 17-Jun-9I
AB63 LISBON CANNIESBURN HOSPITAL NECK WOUND 2 1-Aug-91
AB64 LISBON GLASGOW WESTERN INFIRMARY NK
AB65 LISBON INVERCLYDE HOSPITAL CSF DRAIN 24-Sep-9I
AB 66 LISBON STOBHILL FIOSPITAL BLOOD 26-Oct-94
AB67 LISBON QUEEN ELIZ. HOSPITAL NK
AB68 LISBON STOBHILL HOSPITAL PERM CATHETER 01 -Aug-95
AB 69 LISBON CANNIESBURN HOSPITAL FLAP 2O-J11I-93
AB 70 LISBON GLASGOW ROYAL INFIRMARY U NECK OF FEMUR lO-Jiin-93
AB 71 LISBON GLASGOW ROYAL INFIRMARY NK lO-Jun-93
AB72 LISBON GLASGOW ROYAL INFIRMARY BLOOD 30-JUI1-93
AB 73 LISBON GLASGOW ROYAL INFIRMARY TISSUE IO-Nov-93
AB74 LISBON GLASGOW ROYAL INFIRMARY URINE I2-Jun-91
AB 75 LISBON STOBHILL HOSPITAL APPENDECTOMY WOUND 02-May-96
AB 76 LISBON CROSSHOUSE HOSPITAL NK
AB77 LISBON CROSSHOUSE HOSPITAL NK
AB78 LISBON GLASGOW ROYAL INFIRMARY BLOOD 30-Oct-92
AB 79 LISBON ROYAL ALEXANDRIA HOSPITAL NASAL 07-Jun-93
AB 80 LISBON GLASGOW WESTERN INFIRMARY TRACHEAL ASPIRATE 01-Dec-90
AB 81 LISBON QUEEN ELIZABETH HOSPITAL NK
AB 82 LISBON GARRICK (DUMFRIES) FOOT WOUND 13-Aug-93
AB 83 LISBON VALE OF LEVEN HOSPITAL TRACHEOSTOMY 08-Dec-93
AB 84 LISBON CANNIESBURN HOSPITAL BREAST DISCHARGE 20-Oct-92
AB 85 LISBON GLASGOW WESTERN INFIRMARY TRACHEOSTOMY
AB 86 LISBON NK NK
AB 87 LISBON NEWMAINS HEALTH CENTRE 
(LAW)
WOUND (PIN TRACT) 30-Jul-93
AB 88 LISBON GLASGOW ROYAL INFIRMARY NK
AB89 LISBON GLASGOW ROYAL INFIRMARY SPUTUM 21-Feb-95
AB 90 LISBON CROSSHOUSE HOSPITAL TOE WOUND 16-Jan-9I
AB91 LISBON GLASGOW ROYAL INFIRMARY TRACHEAL ASPIRATE 22-Scp-9I
AB92 LISBON LIGHTBURN HOSPITAL NK I6-N0V-94
â
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Table 2.2 Cont.
STRAIN No. STUDY TYPE HOSPITAL SITE DATE
AB93 LISBON BALLOCHMYLE HOSPITAL CHEST DRAIN I6-Sep-91
AB 100 EMRSA 15 DALRYMPLE HOSPITAL 
(DUMFRIES)
WOUND 27-Sep-93
AB 101 EMRSA 15 GLASGOW ROYAL INFIRMARY NK
AB 102 EMRSA 15 GLASGOW ROYAL INFIRMARY ANAL
AB 103 EMRSA 15 GLASGOW ROYAL INFIRMARY CHEST WOUND
AB 104 EMRSA 15 GLASGOW ROYAL INFIRMARY TRACHEAL ASPIRATE
AB 105 EMRSA 15 GLASGOW ROYAL INFIRMARY SPUTUM I7-Jan-96
AB 106 EMRSA 15 GLASGOW ROYAL INFIRMARY SPUTUM
AB 107 EMRSA 15 GLASGOW ROYAL INFIRMARY SPUTUM
AB 108 EMRSA 15 GLASGOW ROYAL INFIRMARY STUMP WOUND 11 -Jan-96
AB 109 EMRSA 15 STOBHILL HOSPITAL BLOOD I3-Sep-95
AB 110 EMRSA 15 STOBHILL HOSPITAL FEMORAL LINE SITE 22-Jun-95
AB 111 EMRSA 15 STOBHILL HOSPITAL NOSE AND FISTULA 21-Jul-95
AB 112 EMRSA 15 STOBHILL HOSPITAL PD EXIT SITE 24-Jun-95
AB 113 EMRSA 15 STOBHILL HOSPITAL SPUTUM 14-Jui“95
AB 114 EMRSA 15 VALE OF LEVEN HOSPITAL WOUND 09-Sep-94
AB 115 EMRSA 15 WESTERN GENERAL HOSPITAL NK
AB 116 EMRSA 15 WESTERN GENERAL HOSPITAL URINE 02-Nov-94
AB 117 EMRSA 15 WESTERN GENERAL HOSPITAL THROAT 04-NOV-94
AB 118 EMRSA 15 YORKHILL HOSPITAL THROAT
AB 119 EMRSA 16 NK NK
AB 120 EMRSA 16 DUMFRIES ROYAL INFIRMARY ENDO TRACHEAL TUBE
AB 121 EMRSA 16 DUMFRIES ROYAL INFIRMARY NASAL
AB 122 EMRSA 16 DUMFRIES ROYAL INFIRMARY TRACHEAL ASPIRATE
AB 123 EMRSA 16 DUMFRIES ROYAL INFIRMARY WOUND
AB 124 EMRSA 16 GLASGOW ROYAL INFIRMARY TRACHEAL SITE
AB 125 EMRSA 16 GLASGOW ROYAL INFIRMARY WOUND
AB 126 EMRSA 16 HEALTH CARE INTERNATIONAL CHEST WOUND
AB 127 EMRSA 16 HEALTH CARE INTERNATIONAL ORTHOPAEDIC WOUND
AB 128 EMRSA 16 MONKLANDS HOSPITAL BILE
AB 129 EMRSA 16 MONKLANDS HOSPITAL GROIN
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Table 2.2 Cont.
STRAIN No. STUDY TYPE HOSPITAL SITE DATE
AB 130 EMRSA 16 MONKLANDS HOSPITAL PUS
AB 131 EMRSA 16 MONKLANDS HOSPITAL SPUTUM
AB 132 EMRSA 16 STOBHILL HOSPITAL SPUTUM
AB 133 EMRSA 16 WESTERN GENERAL HOSPITAL NASAL
AB 134 EMRSA 16 WESTERN GENERAL HOSPITAL SPUTUM
AB 135 EMRSA 16 WESTERN GENERAL HOSPITAL SPUTUM
AB 136 EMRSA 1 BRISBANE, AUSTRALIA NK
AB 137 EMRSA 1 BRISBANE NK
AB 138 EMRSA 1 BRISBANE NK
AB 139 EMRSA I BRISBANE NK
AB 140 EMRSA 1 BRISBANE NK
AB 141 EMRSA 1 ST. BARTHOLEMEWS NK
AB 142 EMRSA 1 ST. BARTHOLEMEWS NK
AB 143 EMRSA 1 ST. THOMAS NK
AB 146 e n sF BELVIDERE FOOT WOUND
AB 147 ENST CROSSHOUSE HOSPITAL BOIL
AB 148 ENST FOURHILLS NH SACRAL
AB 149 ENST HARTWOOD (LAW) ECZEMA
AB 150 ENST LENZIE FOOT WOUND
AB 151 ENST MONKLANDS HOSPITAL NK
AB 152 ENST STOBHILL HOSPITAL ARTERIAL LINE TIP
AB 153 ENST STOBHILL HOSPITAL CENTRAL LINE TIP
AB 154 ENST STOBHILL HOSPITAL CENTRAL LINE TIP
AB 155 ENST STOBHILL HOSPITAL LEG
AB 156 ENST STOBHILL HOSPITAL LEG
AB 157 ENST STOBHILL HOSPITAL LEG
AB 158 ENST STOBHILL HOSPITAL PEG TUBE
AB 159 ENST STOBHILL HOSPITAL RIGHT HEEL
AB 160 ENST STOBHILL HOSPITAL SACRAL
AB 161 ENST STOBHILL HOSPITAL SKIN
AB 162 ENST STOBHILL HOSPITAL SKIN
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Table 2.2 Cont.
STRAIN No. STUDY TYPE HOSPITAL SITE DATE
AB 163 ENST STOBHILL HOSPITAL SKIN
AB 164 ENST STOBHILL HOSPITAL SKIN
AB 165 ENST STOBHILL HOSPITAL THROAT
AB 166 ENST STOBHILL HOSPITAL URETHRAL
AB 167 ENST STOBHILL HOSPITAL URINE
AB 168 ENST STOBHILL HOSPITAL WOUND
AB 169 ENST WOODSIDE HEALTH CENTRE TOE WOUND
AB 170 ENST YORKHILL HOSPITAL LEG WOUND
AB 144 SPORADIC ROYAL ALEXANDRIA HOSPITAL BAR
AB 145 SPORADIC ROYAL ALEXANDRIA HOSPITAL WOUND
AB 171 SPORADIC CROSSHOUSE HOSPITAL LEG WOUND
AB 173 SPORADIC CROSSHOUSE HOSPITAL FOOT WOUND
AB 174 SPORADIC GLASGOW ROYAL INFIRMARY BACK RASH
AB 175 SPORADIC MONKLANDS HOSPITAL NK
AB 176 SPORADIC VALE OF LEVEN HOSPITAL WOUND
AB 177 SPORADIC HEALTH CARE INTERNATIONAL BLOOD
AB 179 MSSA BOVINE MASTITIS
AB 184 MSSA BOVINE MASTITIS
AB 192 MSSA COMMUNITY NASAL I O-May-93
AB 193 MSSA COMMUNITY NASAL 11 "May-93
AB 194 MSSA COMMUNITY NASAL 12-May-93
AB 187 MSSA COMMUNITY NASAL 13-May-93
AB211 MSSA STOBHILL HOSPITAL LEFT BREAST ABSCESS 02-Dec-93
AB212 MSSA STOBHILL HOSPITAL LEFT EAR IO-Dec-93
AB205 MSSA STOBHILL HOSPITAL ABDOMEN WOUND 06-Dec-93
AB215 MSSA STOBHILL HOSPITAL SINUS TISSUE lO-Dec-93
AB 201 MSSA RUCHILL HOSPITAL GROIN ABSCESS I3-Dec-93
AB219 MSSA WOODILEE HOSPITAL RIGHT EYE 03-Dec-93
AB 196 MSSA GENERAL PRACTICE (GP) EAR I3-Feb-95
AB 197 MSSA GP PERIURETHRAL I3-Feb-95
AB 198 MSSA GP NASAL IO-Feb-95
Y
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Table 2.2 Cont.
STRAIN No. STUDY TYPE HOSPITAL SITE DATE
AB 199 MSSA GP LEG WOUND I I-Fcb-95
AB 200 MSSA GP ULCER I3-Feb-95
AB220 FRENCH
STRAIN
GLASGOW ROYAL INFIRMARY NK 30-0ct-90
AB221 FRENCH GLASGOW ROYAL INFIRMARY NK 15-NoV“90
AB222 FRENCH GLASGOW ROYAL INFIRMARY NK Ol-Oct-90
AB 223 FRENCH GLASGOW ROYAL INFIRMARY NK 01-Nov-90
AB 224 FRENCH GLASGOW ROYAL INFIRMARY NK 27-NOV-90
AB 225 FRENCH GLASGOW ROYAL INFIRMARY NK I8-Ocl-90
AB 226 FRENCH GLASGOW ROYAL INFIRMARY NK 27-NOV-90
AB 227 FRENCH GLASGOW ROYAL INFIRMARY NK 18-NOV-90
AB 228 FRENCH GLASGOW ROYAL INFIRMARY NK I5-NOV-90
 ^Not Known;  ^Endemic Stobhill MRSA
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The inoculum used for performing sensitivity tests was standardised by 
emulsifying a portion from 2 - 3  well-isolated single colonies into a 5ml 
volume of sterile water. The sensitive control strain used was the Oxford 
Staph. (NCTC 6751) and the criteria used for interpretation of sensitivity were:
Sensitive - zone radius equal, wider or not more than 3 mm smaller than the 
control strain.
Resistant - a zone of 2 mm radius or less.
2.4 Bacteriophage typing
All “Lisbon” isolates were phage typed using the International Set of 
Typing Phages (Blair and Williams, 1961) for Staph, aureus initially at 
Gartnavel Hospital in Glasgow and subsequently at the Bacteriology 
Department of the Victoria Infirmary, Glasgow.
2.5 Biotyping
A simplified scheme was used which had been previously employed by 
Coia et al. (1990) to help define outbreaks of infection caused by local strains 
of MRSA at Glasgow Royal Infirmary. All Lisbon isolates were initially 
characterised at the bacteriology department of Glasgow Royal Infirmary or 
Haiimyres Hospitals.
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(a) Urease production
Two to three single colonies were inoculated into 2ml volumes 
in bijoux of brain heart infusion (BHI) broth (Oxoid CM225) containing phenol 
red and 2% urea which was then incubated for 18-48 hours at 37°C (Coia et a l .
1990).
■
(b) Tween 80 hydrolysis
Hydrolysis of Tween 80 was detected on plates containing 1% 
Tween 80 (BDH) in nutrient agar (Nutrient broth, Oxoid CMl, containing 1% 
bacteriological agar, Oxoid L ll) . Ten isolates including a positive and 
negative control were spotted onto each plate and incubated for up to 3 days at 
37“C (Coia er a/., 1990).
'
2.6 Genomic fingerprinting
(a) Buffers and Reagents
Details of all buffers and reagents used are given in appendix I.
(b) Centrifugation
All microcentrifugation was carried out at 13000g in a Heraeus 
microcentrifuge. Larger volumes (5-10ml) were centrifuged at 3000g in a 
Mistral 1000 centrifuge (MSE).
47
(c) Extraction and purification o f  genomic DNA
Genomic DNA was extracted and purified for restriction enzyme #|
fingerprinting by the method of Platt et al., (1996). A well-isolated single 
colony from a pure overnight growth of the organism on horse blood agar was 
inoculated into 10ml of Todd-Hewitt broth and incubated at 37®C for 18-20 
hours.
The culture was then centrifuged for 10 minutes, the supernatant fluid 
discarded and the pellet re suspended in 3 ml of Tris-EDT A-sodium chloride 
buffer (TES). This suspension was divided between 3 sterile Eppendorf tubes, 
microcentrifuged for BOseconds and the deposit re suspended in 200pl o^ T^CSs j^
To this suspension, lOOpl of lysozyme (40mg/ml) and 20pl of 
lysostaphin (lOOOunits/ml) was added. The suspension was vortexed and 
incubated at 37°C for 30 minutes. The cells were lysed by addition of ISjul of 
20% w/v SDS in water followed by gentle inversion.
Cellular proteins were degraded by the addition of 50pl of proteinase K 
(lOmg/ml). Following addition of proteinase K, the DNA was sheaied by 
drawing the solution through a 25G-gauge hypodermic needle. Tubes were 
incubated for two hours at 37^C.
Cellular debris was then removed by addition of 500pl of phenol- 
chloroform and vortexed thoroughly. The tubes were microcentrifuged for 10 
minutes and the upper aqueous layer transferred into clean sterile Eppendorf 
tubes.
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The addition of 500pl of isopropanol either at room temperature for one 
hour or at 4°C for approximately 30 minutes precipitated DNA. The tubes were 
microcentrifuged, the supernate discarded and the pellet resuspended in lOOpl 
of lOmM Tris-EDT A (TEio). The triplicate tubes were pooled, lOOpl of 7.5M 
ammonium acetate added and mixed followed by 600pl of ice cold absolute 
ethanol.
The tubes were vortexed briefly and the nucleic acid mixture 
precipitated overnight at -20^C.
On the following day the DNA was microcentrifuged for 10 minutes, 
the supernate discarded and pellet resuspended in 300pl of TEio. To this was 
added 20 pi of RNAse (lOmg/ml) to degrade RNA. The tubes were incubated 
for one hour at 37®C.
This was followed by a second phenol-chloroform extraction, 
isopropanol precipitation, and overnight ethanol precipitation at -20^C as 
described above.
The DNA was made ready for digestion by microcentrifugation of the 
ethanol precipitate for 10 minutes and the dried pellet resuspended in 60pl of
TE.
(d) Restriction enzyme digestion o f genomic DNA
A 20pl aliquot of the purified DNA was added to a reaction mixture 
that contained 2pl of restriction enzyme, 5 pi of appropriate reaction buffer and 
23 pi of sterile distilled water to give a final reaction volume of 50pl.
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Fragment size calibrators were included on each gel using Kpn\ and Pst\ 
digests of phage lambda (A.) DNA. These were prepared as outlined above but 
with addition of only 2pi of DNA and the volume of water adjusted to 41 pi.
All samples were vortexed then microcentrifuged for five seconds to
ensure contact between all reactants. The tubes were incubated at 37°C for four
hours to ensure complete digestion prior to electrophoresis.
(e) Horizontal gel electrophoresis
Electrophoresis was carried out in a Maxi - Plus Horizontal 20cm x 
30cm Unit (Anachem) using a E321 power pack (Consort).
A 0.6% gel was prepared by adding 3g of Agai’ose (Sigma) to 500ml of 
Tris-borate-EDTA buffer (TBE). This was heated until dissolved and left to 
cool to approximately 45^0 after which the molten gel was cast into a 20cm x 
30cm gel tray and a 28 well comb placed in position.
The gel was left to set for at least one hour, placed in the electrophoresis 
tank and submerged in two-thirds strength rumiing buffer (TBE).
After incubation, 5 pi of tracking dye were added to all digested samples 
and calibrators. These were mixed and 50pl aliquots carefully loaded into the 
submerged wells in the gel. Samples were run at 32mA for a minimum of 
221u's.
(f) Visualisation o f DNA fragments
After electrophoresis the gel was stained for 30 minutes in a solution of 
ethidium bromide (0.5pg/ml). Fragments were visualised under ultraviolet
50
light (302nm) and photographed on Polaroid Type 665 film with a Polaroid 
MP4 land camera.
2.7 Plasmid Profiling
(a) Preparation o f  cell lysates
Crude lysates were prepared for plasmid profiles by a modification of 
the method of Coia et al. (1988). Approximately 25% of the growth from an 
overnight culture on Oxoid nutrient agar (Unipath) was harvested into 500pl of 
TES in sterile Eppendorf tubes. The tubes were vortex mixed then 
microcentrifuged to pellet the cells. The supernate was discarded and the pellet 
resuspended in 400pl TES S. Addition of lOOpl of lysozyme (40mg/ml) and 
20pl of lysostaphin (lOOOunits/ml) digested the cell walls. Following vortex 
mixing and incubation at 37°C for 30 minutes, 400pl of 10% w/v SDS was 
added to lyse the cells. The lysates were microcentrifuged for 10 minutes and 
clu'omosomal DNA removed with a broken swab stick.
Plasmid sizes were estimated by comparison to plasmids of known size 
from E. coli strain 39R861. This strain contains four plasmids of 151Kb, 
67Kb, 38Kb and 7.4Kb (Macrina et al., 1978). The E. coli crude lysate was 
prepared by harvesting 25% of overnight culture on nutrient agar into 600pl 
TES in Eppendorf tubes. This was vortex mixed and 400pl of 10% SDS added 
to lyse the cells. Subsequent steps in plasmid preparation were as per the 
Staph, aureus protocol.
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(b) Vertical gel electrophoresis
One hundred microlitres of the crude lysate were mixed with 5 pi of 
tracking dye and added to each well of a vertical agarose gel (0.7% w/v in TBE 
buffer). Separation of plasmids was achieved by electrophoresis in TBE buffer 
at lOOV for 30 minutes to one hour followed by 200V for five hours (Platt and 
Sommerville, 1981). The gels were carefully removed from the vertical slab 
apparatus and stained in ethidium bromide (0.5pg/ml) for 30 minutes and 
photographed as described above.
2.8 Plasmid fingerprinting
(a) Extraction and purification ofplasm id DNA
Cultures incubated at 37”C overnight in 10ml of BHI broth were 
centrifuged for 10 minutes, the supernate discarded, pellet resuspended in 2ml 
of TES and split equally into two Eppendorf tubes. The tubes were 
microcentrifuged for 30 seconds and the pellets resuspended in 200pl of TESS. 
50pi of lysozyme (40mg/ml) and 20pi of lysostaphin (1 mg/ml) were added 
followed by incubation at 37°C for 10-30 minutes.
Alkaline SDS was prepared fleshly by adding 1ml of 10% w/v SDS to 
1ml of 2M sodium hydroxide (NaOH) and making up to 10ml with sterile 
distilled water to give 1% SDS in 0.2M NaOH. Four hundred micro litres of 
this solution was added to each tube and mixed by inversion to complete cell 
lysis.
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The tubes were then incubated on ice for 5 minutes following which 
300pl of 3M sodium acetate was added and mixed gently by inversion to 
precipitate the chromosomal DNA.
The tubes were vortex mixed and incubated again on ice for five 
minutes, microcentrifuged for two minutes and the supernate transferred to 
clean sterile Eppendorf tubes. Five hundred microlitres of phenol-chloroform 
(1:1) mixture was added to each tube, vortex mixed and microcentrifuged for 
two minutes. The upper aqueous layers from each tube were carefully removed 
into clean sterile Eppendorf tubes, 500pl isopropanol added, vortex mixed and 
left at room temperature for 10 minutes to precipitate nucleic acids. The tubes 
were then microcentrifuged for five minutes, the supernate discarded and the 
pellets resuspended in lOOpl of TE buffer (lOmM Tris, ImM EDTA, pH 8.0). 
Following resuspension of the nucleic acids, the tubes were vortex mixed and 
duplicate tubes pooled. One hundred microlitres of 7.5M ammonium acetate 
were then added to the DNA solution followed by 600pl of ice cold ethanol. 
Samples were vortex mixed and left overnight at -20°C. The samples were 
microcentrifuged for 2 minutes, the supernate discarded and the resulting 
nucleic acid pellets resuspended in 160pi of TE. The RNA fraction of the 
samples was digested by the addition of 18 pi of RNAse (1 mg/ml) followed by 
a 30-minute incubation at 37°C. This was followed by addition of 20pl 2.5M 
sodium chloride vortex mixing and a second round of phenol / chloroform 
extraction, isopropanol and ethanol precipitation as described above.
To prepare the DNA for digestion, the samples were microcentrifuged 
for two minutes, supernate discarded and the purified plasmid DNA precipitate
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resuspended in 60pl of TE. The digestion of the plasmid DNA followed the 
same protocol as for digestion of genomic DNA.
(b) Horizontal gel electrophoresis
On completion of digestion, 5 pi of tracking dye was added to each 
reaction tube. A horizontal 0.8% agarose gel containing ethidium bromide 
(0.3pl/ml) was made up in 100ml of TBE. When set, the gel was placed in a 
horizontal gel tank (Life Technologies Model H3) and submerged in TBE 
containing ethidium bromide. The samples were loaded and run at 18mA 
overnight. The following morning the gel was viewed and photographed as 
described above.
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2.9 Computer aided analysis of gels
(a) Calculation o f  similarity coefficients i
Restriction fragment mobility in ethidium bromide stained agarose gels
was recorded on Polaroid film and this data transferred to computer using a
Summagraphics digitiser and commercially available software (Platt and
Sullivan, 1992). Each gel was calibrated with restriction fragments from both
Pstl and Kpnl digests of X DNA. The molecular weights of these fragments
were fitted to a robust modified hyperbola (Plikaytis et al, 1986) from which
fragment sizes in adjacent tracks were estimated by interpolation. The
numerical values (kb) were stored for subsequent calculation of similarity
coefficients (Dice, 1945) and graphical output (logarithmic scale). A fragment
size variation of 5% was set to account for small variations in the lambda 
____________________________________________________________________________
calibrators within and between gels and operator error with the use of the 
digitiser. The calculation of Dice coefficients of similarity was based on the 
formula:
Sd (%) = [2m/(a+b)] x 100
Where “m” was the number of restriction fragments common to two isolates 
and “a” + “b” was the total number of fragments digitised from each isolate.
(b) Construction o f  dendrograms
Dendrograms were constructed from transformed distance matrices of 
REFP data using the Neighbour Joining method of Saitou and Nei (1987). 
Because the dendrograms depict only a small amount of the data from within 
the matrix, the topology of any tree contains uncertainty. One of the major 
determinants can be data input order. This was assessed by comparing the 
output from three data input orders and additionally by the calculation of the 
root mean squared (RMS) distance between the matrix and the generated tree.
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3.1 Genotyping of Staph, aureus control strains with the 
restriction endonuclease H hal
(a) Methicillin-sensitive Staph aureus (MSSA)
This group comprised seventeen epidemiologically unrelated isolates 
from healthy nasal carriers in the community (4), hospital and GP isolates from 
sites of infection (11) and isolates from cases of bovine mastitis (2).
The size of restriction fragments amenable to computer analysis ranged 
from 3.7kb to 15.6kb. The number of fragments amenable to computer 
analysis ranged from 8 (AB211) to 21 (AB193, AB194). When each isolate 
was matched with one another, Dice coefficients of similarity (S d values) 
ranged between 33 - 93% with a mean Sd of 66%.
Visual comparison of the REFP's indicated considerable diversity 
among epidemiologically umelated strains. Estimation of relatedness using Sd 
values provided a more quantitative perspective against which sub-groups of 
MRSA could be assessed as described below. The range indicated that some 
strains were veiy distantly related (AB194 & AB205, Sd = 33%), whereas 
others appeared closely related by Dice coefficient analysis, although not by 
visual analysis of gels or the digitised print-out as shown in Figure 3.1(AB193 
& AB212, Sd= 93%). This was probably as a result of coincidental matching 
among smaller fragments. Matching the isolate of Staph., hyicus with these 
MSSA isolates gave a range of Sd values from 21 - 74% with a mean Sd of 
53%, indicating only distant relationships with MSSA strains as would be 
expected from a different staphylococcal species.
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A digitised representation of the REFP’s of these isolates is shown in 
Figure 3.1 and the range of Sd values is shown in Figure 3.2. The mean value 
of 66% also corresponds to the mode of the distribution. However, the 
distribution is asymmetric and indicates that a small number of unrelated 
strains showed high levels of similarity.
An example of matching pair data and fragment sizes is shown in 
appendix II.
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Figure 3.1
D igitised representation oîH hal R E FP’s o f  epidem iologically unrelated
M SSA  isolates
M(rt+Jc0)%«S
AB187, 192 - 194, community nasal isolates; AB196 - 200, GP isolates; AB201, 205, 211, 
212, 215, 219, nosocomial isolates; AB179 & AB184, bovine mastitis isolates.
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Figure 3.2
The range of Sd values found among the study MSSA isolates
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(b) Methicillm-resistant Staph, aureus (MRSA)
Sixty-one non-Lisbon MRSA's were genotyped on the basis of Hhal 
REFP's. This included examples of previously phenotyped EMRSA-1, 
EMRSA-15 and EMRSA-16. A table containing details of all study isolates 
and their designated strain numbers is given in the Materials and Methods 
section (Table 2.2).
(i) EMRSA 1
These eight isolates had previously been designated EMRSA-1 on the 
basis of their phenotypic characteristics. Two were from St Bartholomew's 
Hospital, one from St. Thomas’ Hospital in London, and five from an outbreak 
in Brisbane, Australia. The two isolates from St Bartholomew's (AB 141 and 
AB 142) gave identical Hhal REFP’s, there was a two fragment difference 
between them and the isolate from St. Thomas’s (AB 143). The Brisbane 
isolates showed a greater degree of similarity to the St. Thomas's isolate than to 
the St. Bartholomew's although the whole group were closely related. A 
digitised representation of Hhal REFP's of these isolates is shown in Figure 
3.3. Chromosomal fragments amenable to computer analysis ranged in size 
from approximately 3.8kb - 14.2kb. So analysis demonstrated the genomic 
variation and demonstrated that Hhal REFP's discriminated strains 
homogeneous on the basis of phenotype (range 84 - 100%; mean 92%). The 
range of Sd values is illustrated in Figure 3.4.
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Figure 3.3
D igitised representation o f  Hhal R E F P ’s o f  EM R SA-1 isolates
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AB136 - 140, EMRSA-1 from Brisbane, Australia; AB141 & AB142, identical EMRSA-1 
isolates from St Bartholomews Hospital, London; AB143, EMRSA-1 isolate from St. 
Thomas* Hospital, London.
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Figure3.4
The range o f  So values found am ong EM RSA-1 variants
m in in
% similarity (Sq)
representation of all EMRSA-15 isolates illustrating the thiee Hhal variants is 
shown in Figure 3.6. Although a further polymorphism was evident in some 
strains this was later shown to be due to plasmid DNA.
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(ii) EMRSA-15
Nineteen EMRSA-15 from six different sources were typed. Three of gy
these isolates had originally been included in the “Other” MRS A group and had I
not originally been recognised as EMRSA-15 isolates. Three Hhal genomic 
variants were seen among the EMRSA-15. The predominant type of which I
there were 16 isolates was designated type 15-Hl, two isolates with a single 
fragment difference were designated type 15-H2 and a single isolate contained
I
an additional fragment and was designated type 15-H3. A gel photograph Ishowing examples of Hhal and Sau3Al REFP’s of EMRSA-15’s is shown in
.Figure 3.5. Chromosomal fragments amenable to computer analysis ranged in
isize from approximately 3.9kb - 11.6kb. Isolates AB109, 112 and 113 exhibited |
the type HI polymorphism and ABllO exhibited the type H3 polymorphism.
The largest Hhal fragment of these isolates is of plasmid origin. The SauSAl 
digest shown here was typical of all EMRSA-15 study isolates. A digitised
I
Figure 3.5
Hhal and Sau3A\ REFP's o f EM R SA -15 isolates.
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Lanes U4, Hhal REFP's; AB112, 113 and 109 are E15-H1 variants, and A BllO  is variant 
E15-H3. Lane 5, .Saw3AI REFP - no variation was seen among ElVIRSA-15 with this 
enzyme. Lanes 6 and 7 contain respectively, Pstl and Kpnl digests of phage lambda DNA. 
Plasmid REFP's of these isolates showed the largest densely staining fragment of these 
isolates to be plasmid in origin.
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Figure 3.6
Digitised representation of all EMRSA-15 Hha\ REFP’s.
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REFP's from isolates ABIOO and AB114 exhibit the Hha\ type, EI5-H2. The REFP of 
isolate ABIIO exhibits the Hha\ type, E15-H3 and all other REFP's exhibit the Hha\ type 
EI5-H1.
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Sd analysis of these variants showed a range of 98 - 100%, with a mean 
Sd of 99%. Although two isolates (ABIOO, A BU4) were visibly a variant with 
respect to a single fragment, they appeared to match at 100%. This was as a 
result of software limitations. Figure 3.7 shows the range of Sd values for the 
EMRSA-15 variants.
Hhal genotyping confirmed phenotypically identified EMRSA-15 
isolates responsible for outbreaks of infection in the Intensive Care Unit at 
Glasgow Royal Infirmary and the Renal Unit at Stobhill Flospital.
Hhal REFP's and So analysis comparison of the variants within each 
control group showed EMRSA-15 to be genetically very distinct from 
EMRSA-1. When the groups were matched with each other. So values ranged 
from 62 - 79% with a mean of 70%. The mean of these matches was 
considerably less than the mean values for each group alone.
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Figure 3.7
The range of Sd values found among EMRSA-15 variants
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(iii) EMRSA-16
Seventeen EMRSA-16 from seven different sources were typed. On the 
basis of typing, four outbreaks were confirmed: at Monklands Hospital, 
Western General Hospital, Dumfries Royal Infirmary and Glasgow Royal 
Infirmary, and a further two cases were confirmed at Health Care International 
Hospital (FICI). All isolates were very closely related. Nine were identical and 
were designated type 16-HI, four sub-types were also identified, comprising 
3,2,2 and a single isolate, designated 16-H2, H3, H4 and H5 respectively, each 
with 1 - 3  fragments different from the dominant type. A gel photograph 
showing examples of Hhal and SauiAl REFP’s is shown in Figure 3.8. 
Chromosomal fragments amenable to computer analysis ranged in size from 
approximately 4.2kb - 10.6kb. A digitised representation of all the EMRSA-16 
Hhal REFP's is shown in Figure 3.9.
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Figure 3.8
G el photograph o f HhaV and SauSAV R E FP’s o f EM R SA -16 isolates.
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The numbers on the left of the figure indicate the fragment sizes in kb of the Ps/l and 
Apnl digests respectively of lambda phage DNA in the centre of the gel.
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Figure 3,9
Digitised representation of all EMRSA-16 H hal REFP’s
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Lanes 1-9: Hhal REFP type E16-H1; lanes 10 - 11: REFP type E16-H3; lanes 12 - 14: 
REFP type E16-H2; lane 15: REFP type E16-H5; lanes 16 -17: REFP type E16-H4.
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When Sd analysis was performed on the genomic variants within this 
group, a range of 91 - 98% similarity was found, with a mean Sd of 94% as 
illustrated in Figure 3.10.
Sd analysis of inter-gi'oup matching showed that this strain was 
genetically distinct from EMRSA-1 and EMRSA-15. When matched with 
EMRSA-1, Sd values ranged from 62 - 76% with a mean value of 69% and 
when matched with EMRSA-15, Sd values ranged from 70 - 73 with a mean of 
72%L
The comparison of EMRSA-1, EMRSA-15 and EMRSA-16 using Sd 
analysis was valuable in the assessment of the discriminatoiy power of Hhal 
REFP's. In each instance minor variations were demonstrated within the group 
but between each group substantial diversity was evident. This indicated that 
Hhal REFP's not only reflected similarity when strains were closely related but 
also that they did not do so tlirough a lack of discriminatory power.
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Figure 3.10
The range of So values found among EMRSA-16 variants
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(iv ) Other MRSA 
(a) “Stobhill type”
From the total of 18 MRSA that did not conform to any recognised 
epidemic group, ten isolates were shown to be genetically related by Hhal 
REFP analysis. Six of these isolates originated from wards within Stobhill 
Hospital whereas a further four isolates were from different hospitals (see 
Figui'e 3.14, isolates AB146, 147, 149 and 151). Eight variants were found, 
with 3 isolates from Stobhill belonging to a single REFP type (AB152, AB160, 
and AB166). Chromosomal fragments amenable to computer analysis ranged 
in size from approximately 4.6kb - 17kb. A digitised representation of these 
variants is shown in Figure 3.11.
Sd analysis of these variants indicated a range of 76 - 100%, with a 
mean So of 89%. Although two isolates differed in two fragments (AB146 and 
AB163), they matched at 100%. Again this was due to computer software 
limitations. When the matching pair analysis was repeated allowing for no 
fi'agment size variation, the Sd values ranged from 69 - 96% with a mean Sd of 
84%. This showed a margin of error of 5.5% between the two variations in 
analysis. The range in So values for this group is shown in Figure 3.12.
Sd analysis of inter-group matching showed that this group was 
genetically distinct from EMRSA-1, EMRSA-15 and EMRSA-16. When 
matched with EMRSA-1, Sd values ranged from 55 - 71% with a mean value 
of 60%, when matched with EMRSA-15, Sd values ranged from 47 - 62 with a 
mean of 53% and when matched with EMRSA-16, Sd values ranged from 47 - 
67 with a mean of 57%.
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Figure 3.11
D igitised representation oîH hal R E FP's o f  the M R SA  " type" found to be
prevalent in Stobhill Hospital
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Figure 3.12
The range of Sd values found among MRSA isolates belonging to the 
tentatively named **Stobhill clone”
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(b) Sporadic MRSA
Eight isolates were defined as "sporadic" on the basis that they were not 
phenotypically recognisable as epidemic strains, and were revealed by their 
Hhal REFP's to be the most diverse MRSA group. When S d analysis was 
performed on these isolates, a range o f 69 - 100% similarity was found, with a 
mean Sd of 82%. Two isolates from different wards at the same hospital 
matched at 100% (AB144 & AB145). Another two isolates, AB171 & AB176 
were closely related to each other, having only a one fragment difference ( S d 
97%) and to the two identical isolates (S d  90% & 93% respectively). The other 
four isolates of this group appeared to be more diverse both by visual 
inspection of gel photographs and by computer analysis. A digitised 
representation o f Hhal REFP's of these isolates is shown in Figure 3.13.
The analysis of this group of isolates by Hhal REFP's indicates the 
ability of the technique to discriminate among different strains of MRSA and 
also to sub-type within a single strain. The data also suggests that as in the case 
of MS SA isolates, genetic relationships between epidemiologically unrelated 
MRSA strains can also be found. MRSA having had less time to diverge than 
MS SA are predicted to be somewhat less diverse therefore it was not 
unexpected that the Sd values indicated this, although this observation must be 
balanced with the fact that the MSSA group contained more than twice the 
number of isolates.
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Figure 3.13
Digitised representation of H hal REFP's from isolates initially classed as 
sporadic MRSA
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Examples of Hhal REFP's of MRSA that belonged to the Stobhill group 
and other mixed MRSA are shown in Figure 3.14.
Lanes 10, 11 and 12 contained, respectively, Psil, Kpnl and Hhal 
digests of phage lambda DNA. Lanes 1, 3 and 7 contained REFP’s of 
EMRSA-15 isolates (ABIOO, Dumfries Royal Infirmaiy; AB118, Yorkliill 
Hospital; AB114, Vale of Leven Hospital) which prior to this study had not 
been recognised as such. Lane 9 contained a Lisbon type HI REFP (AB5). No 
DNA was present in lane 2, while lanes 4 and 5 contained REFP’s from 
identical sporadic isolates ( S d = 100%) obtained from different wards at the 
same hospital (AB145 and AB144, RAH). The REFP’s in lanes 8 and 15 
(AB176, Vale of Leven; AB171, Crosshouse) were very similar ( S d = 91%).
type.
The REFP’s in lanes 14, 16, 18 and 20 (AB147, AB146, AB149 and 
AB151 respectively) were from isolates originally included in the “Other” 
MRSA group, however visual and Sd analysis revealed them to be closely 
related to each other and to the Stobhill clone. The true degree of genomic 
relatedness between these four isolates on this gel was somewhat complicated 
by the presence of a number of intensely staining fragments which may have 
been of plasmid origin.
Finally, the isolates in lanes 13, 17 and 19 (AB173, AB174, and 
AB175) were sporadic MRSA, unrelated both phenotypically and 
genotypically.
* • • Phenotypically, these isolates were almost identical, but they differed in phage
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Figure 3.14
G el photograph show ing Hhal genom ic REFP's o f a m ixed selection o f
M RSA isolates
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3.2 Genotyping of Staph, aureus control strains with the 
restriction endonuclease Sau3Al
Digestion with Sau3A\ yielded fewer discernible fragments under 
identical electrophoresis conditions and did not appear to be as discriminatory 
as Hhal. Isolates that showed identical Hhal fingerprints also showed identical 
Sau3Al fingerprints although the converse of this was not always true. This 
indicated a greater degree of discrimination with Hhal.
Because of the preliminary results obtained with Sau3Al and the 
expense of this enzyme, it was decided only to perform fingerprinting on a 
selection of the total number of isolates. REFP's of a selection of MRSA that 
were shown to be genetically diverse with Hhal were digested with Sau3Al and 
are shown in Figure 3.15.
Lanes 1 and 2 showed, respectively, Pstl and Kpnl REFP's of phage 
lambda DNA. Lanes 3 - 8  showed MSSA REFP's from nasal (3&4), 
nosocomial infections (5&6) and bovine sources (7&8). Lane 9 contained a 
sporadic MRSA. Lanes 10 and 11 contained EMRSA-15 REFP's. The 
EMRSA-15 in lane 11 was both genetically (type 1) and phenotypically (phage 
type 75w) typical of the strain. However, the EMRSA-15 in lane 10 was a 
Hhal variant (type 2) and also a Sau3Al genomic variant and was also the only 
EMRSA-15 to differ markedly phenotypically (phage type 6w 42E 47w 75w 
and erythromycin sensitive). The two intensely stained fragments are probably 
plasmid DNA. The figure shows these isolates to have distinct Sau3Al 
fingerprints. The isolate in lane 10 was also shown to have a different plasmid
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fingerprint to that of other EMRSA-15 s. Cleaiiy, further work is necessary to
establish the relationship of this isolate to other EMRSA-15’s. i
Lane 12 showed an EMRSA-16 REFP. As is also shown in Figure 3.8, 
the SauSAl cleaved the isolates of this strain into numerous small fragments 
that were not amenable to computer analysis. Lanes 13 and 18 contained 
typical Lisbon isolate REFP's {Hhal type HI). Lanes 14, 15 and 16 contained 
EMRSA-1 REFP’s which had minor differences in their Hhal fingerprints but 
have identical SauSAl fingerprints. The DNA in lanes 4 and 17 was from 
MSSA which for reasons as yet unknown, failed to digest on two separate 
oceasions. One possible explanation may be that these isolates are producers of 
SauSAl. Organisms introduce méthylations into their DNA to proteet 
themselves from the action of the restriction enzymes they produce.
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Figure 3.15
Gel photograph showing SaulAX genomic REFP's of a selection of diverse 
Staph, aureus isolates.
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Lanes I and 2 contain respectively, REFP’s o f Pst\ and Kpnl digests of phage lambda 
DINA as size markers. Numbers on the left o f the figure indicate the sizes of lambda 
fragments in kb.
83
3.3 Genotyping of Lisbon strain MRSA with Hhal
Having established that Hhal was highly discriminating in 
differentiating different strains of Staph aureus^ ninety-three isolates of Lisbon 
strain MRSA were genotyped using this enzyme.
Digestion and electrophoresis with Hhal produced 1 8 - 2 4  discernible 
fragments that were amenable to computer analysis. These ranged in size from 
approximately 3.7kb to 15kb as shown in Table 3.1.
Sixty-eight isolates (73%) gave a genomic fingerprint identical to the 
index case and were designated Hhal type HI.
A typical HI type was selected at an early stage of the study and digests 
of this were used on subsequent gels to determine the strain’s genomic stability 
and also to control the DNA extraction and digestion teclinique. This was the 
study isolate designated AB5. The REFP of this control isolate remained stable 
following daily subeulture on horse blood agar both at 37°C and 42°C over a 
six month period. The origins and dates of isolation of the Lisbon variants 
where known, are given in Table 3.2.
Seven isolates lacked the 5.8kb fragment of type HI and were 
designated type H2. REFP's of six isolates showed an additional fragment of 
6.4kb and were designated type H3. Two isolates lacked the 8kb fragment of 
type HI and were designated type HIO. Ten isolates gave unique fingerprints 
and were designated types H4 - 9 and H ll -14. Fragments lost or gained in 
these isolates are shown in Table 3.1.
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All apparent fragment variation occurred among fragments greater than 
or equal to 5.3kb.
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Table 3.1
Genotypic variation seen among Lisbon strain variants (H2 -  H14) as 
compared to the predominant strain type HI
H1 Approximate 
Fragment sizes  
f m  (No.)
H2 H3 H4 HS H6 H7 H8 H9 HIO H11 H12 H13 H14
15.0 
12.6
11.7
8.0 
6.8
5.8
5.3
5.1
4.9
4.7
4.6 
4.5
4.3
4.2 
4.1 
4.0 
3.95
3.9
3.8
3.7
Additional
Fragments
( 1 )
( 2 )
(3 )
(4 )
(5 )
( 6 )
(7 )
( 8 )
(9 )
( 10) 
( 1 1 ) 
(12)
(13)
(14)
(15)
(16)
(17)
(18)
(19)
(20)
Abs
DNA ioss/gain -5.8
Abs
Abs
Abs
Abs
6.4
+6.4 -5.3
6.4
- 11.1 - 6.2
6.4
10.1
6.4
6.6
7.7
Abs
Abs
5.5
+16.5 +20.7 +0.2 -8.0
6.2
6.4
7.4 
8.3 
+28.3
6.2
6.4
Abs
6.2
8.15
6.4
8.3
+12.6 +0.35 +14.7
Abs; Absent
8 6
Table 3.2
O rigins of L isbon strain variants
LISBON VARIANT LOCATION DATE
H2 Glasgow Royal Infirmary 
Glasgow Royal Infirmary 
Glasgow Royal Infirmary 
Glasgow Royal Infirmary 
Glasgow Royal Infirmary 
Canniesburn Hospital 
Stobhill Hospital
12.06.91
10.06.93
10.06.93
30.06.93
10.11.93
20.07.93 
02.05.96
H3 Western Infirmary Glasgow 
Royal Alexandra Hospital 
Glasgow Royal Infirmary 
Queen Elizabeth Hospital 
Crosshouse Hospital 
Crosshouse Hospital
01.12.90
07.06.92
30.10.92 
NK
NK
NK
H4 Dumfries Royal Infirmary 13.08.93
H5 Vale of Leven Hospital 08.12.93
H6 Canniesburn Hospital 20.10.92
H7 Western Infirmary Glasgow NK
H8 NK NK
H9 Law Hospital 30.07.93
H10 Glasgow Royal Infirmary 
Glasgow Royal Infirmary
21.02.95
NK
H11 Crosshouse Hospital 16.01.91
H12 Glasgow Royal Infirmary 22.09.91
H13 Lightburn Hospital 16.11.94
H14 Ballochmyle Hospital 16.09.91
NK: Not Known
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Figure 3.16 shows a gel photograph of a selection of Lisbon strain 
isolates following Hhal digestion and electrophoresis.
Lanes 3, 13 and 16 contained DNA from Lisbon variants H9, HIO and 
H2 respectively. Lanes 7, 8 and 9 contained Kpnl, Pstl and Hhal digests 
respectively of phage lambda DNA. All other lanes contained DNA from 
Lisbon type H I. The isolate in lane 11 was later found to be plasmid - free. 
The gel photograph shows that it lacked the enhanced fragment shown by all 
the other isolates, as indicated by the arrow.
A digitised representation of the fourteen molecular valiants of this 
strain is shown in Figure 3.17. Note that fragment 12 of variant H3 is less 
intense than the equivalent sized fragment of the other variants. This was due 
to this valiant being plasmid free whereas all others possessed an identical 
plasmid which when digested with Hhal yielded a fragment of approximately 
5kb that enhanced the density of this band (see also Figure 3.16)
Sd analysis of the Lisbon variants gave a range of 86 - 100%, with a 
mean Sd of 95%. Two matches occurred at 100%; HI and FI9, and H3 and 
H I3. Although the isolates within each pair had identical numbers of 
fragments (20 and 21 respectively) there were small differences in the size of a 
single fragment which was within the set 5% fragment size variation. These 
isolates had been run together on at least two occasions and fragment size 
differences were deemed to be genuine, although beyond the analytical 
resolution limits of the computer system. Thus the computer based analysis 
potentially overestimated similarity compared to visual inspection which 
recognised subtle differences as significant.
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Figure 3.16
G el photograph show ing Hha\ genom ic R EFP’s o f a selection o f  Lisbon
strain isolates
14.1 
11.5
5.1
4.7
4.5
2.8
Ü U I p a g M g g S
Plasmid
enhanced
band
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
m 00 ^  M rym 3 m m< <; < < cs m m 00 .-I r»5 5 9 5 S 9 S 9 5
Lane 3, variant H9; Lane 13, variant HIO; Lane 16, variant H2; Lane 11, plasmid free 
isolate of type HI; Lanes 7, 8 and 9, Ap/il, Pst\ and Hha\ digests respectively of phage 
lambda DNA; all other lanes, variant HI.
Numbers on left of figure indicate Pst\ size marker fragments in kb.
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Figure 3.17
Digitised representation of Hhal REFP's illustrating the range of 
genotypic variation found among Lisbon and French strain MRS A
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Lisbon variant H4 and French variant H5 have identical REFP’s.
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Sd analysis of inter-group matching showed that this strain was 
genetically distinct from EMRSA-1, EMRSA-15, EMRSA-16 and the Stobhill 
clonal group. When matched with EMRSA-1, So values ranged from 62 - 78% 
with a mean value of 71%. When matched with EMRSA-15, Sd values ranged 
from 65 - 82% with a mean of 74%. When matched with EMRSA-16, Sd 
values ranged from 44 - 64% with a mean of 55% and when matched with the 
Stobhill clone, Sd values ranged from 43 - 67%, with a mean of 52%.
From the results of Hhal genomic REFP typing, a possible evolutionary 
sequence of events was proposed to account for the variation in the REFP's of 
the Lisbon strain in Scotland following its introduction. This is shown in 
Figure 3.18.
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3,4 “French strain” MRSA
Nine isolates from Glasgow Royal Infirmary, that included one from a 
member of staff, were typed with Hhal. These isolates although related by 
comparison of their REFP's showed a number of polymorphisms and could be 
subdivided into five subtypes designated FHl - 5, consisting of 2, 3, 2, 1 and 1 
isolates respectively. Digitised representations of the Hhal REFP's of these 
isolates are shown in Figure 3.17. From this data it was found that an isolate of 
the French strain (AB 228) was identical in genomic REFP to Lisbon variant 
H4 (AB 82).
When Sd analysis was performed on these isolates, a range of 91 - 98% 
similarity was found, with a mean Sd of 95%. When Lisbon and French 
variants were matched with one another, Sd values ranged from 86 - 100% with 
a mean Sd of 94%. Given the high So values found when isolates from the 
other MRSA clonal groups were matched internally, (Table 3.3) and the 
considerably lower Sd values found when matching clonal groups with each 
other, (Table 3.4) this is strong evidence to suggest that the French and Lisbon 
isolates belong to or are derived from a common clonal ancestor as proposed in 
Figure 3.18.
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Figure 3.18
Lisbon strain (LH) and French strain (FrH) Hhal variants: possible 
evolutionary sequence
LHIO LH6
LH7 ?LH11
(-1)
(+2)(+1)
LH14
+1)
^  ?LH8► L H lLHl (+2)(+1)
(+1) LH12(-1)
LH4/FrH5 LH2
(+1) ( 1) 7LH13
LH5LH9
(-1)
(+2) 
?FrH2
Figures in brackets represent DNA fragments lost or gained.
Variants prefixed by denote an evolutionary sequence involving more than one 
genetic event.
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Table 3.3
Dice coefficients of intra-group matching
GROUP
MSSA
Sd Range Mean Sp
33 - 93 66
EMRSA-1 84-100 92
EMRSA-15 98-100 99
EMRSA-16 91-100 94
STOBHILL
MRSA
76-100 89
LISBON
MRSA
86-100 95
FRENCH
MRSA
91 -100 95
SPORADIC
MRSA
69-100 82
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Table 3.4
Dice coefficients of inter-group matching
MATCHED GROUPS S d  Range Mean S d
EMRSA-1 V EMRSA-15 6 2 -7 9 70
EMRSA-1 V EMRSA-16 6 2 -7 6 69
EMRSA-1 V STOBHILL 55-71 60
EMRSA-15 V EMRSA-16 7 0 -7 3 72
EMRSA-15 V STOBHILL 4 7 -6 2 53
EMRSA-16 V STOBHILL 4 7 -6 7 57
LISBON V EMRSA-1 6 2 -7 8 71
LISBON V EMRSA-15 6 5 -8 2 74
LISBON V EMRSA-16 4 4 -6 4 55
LISBON V STOBHILL 4 3 -6 7 52
LISBON V FRENCH 86-100 94
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Figure 3.19 illustrates graphically, the matching of Lisbon strain 
variants with the variants from the other MRSA groups. The results indicate 
that the Lisbon and French MRSA were closely related and should be 
considered as variants that were introduced into Glasgow on two separate and 
epidemiologically unrelated occasions.
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Figure 3.19
Sd values of Lisbon strain variants matched with each other and with 
variants from the other MRSA groups
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97
3,5 Genotyping of Lisbon strain MRSA with Sau3A\
Digestion of the fourteen Lisbon Hhal variants with Sau3Al yielded 7 
variants with 7 isolates belonging to a single type, as shown in Figure 3.20. 
Hhal types HI, H3, H4, H6, Hl l ,  H12, and H14 had identical REFP’s and 
were designated Sau3Al Type 1. Hhal types H2 and H7 were designated 
Sau3Al Type 2 and Hhal types H5, H8, H9 and HIO were designated Sau3Al 
Type 3,4,5 and 6 respectively.
Twenty-tluee isolates of the major Hhal type, HI were chosen at 
random and digested with Sau3Al. One variant was found (AB07) with a two- 
fragment difference as shown in Figure 3.21.
As the restriction enzyme Hhal gave clearer fingerprints with a greater 
number of discernible fragments, it was decided to use this data for statistical 
analysis.
98
Figure 3.20
Gel photograph show ing Sau3A\ R E FP’s o f Lisbon strain Hhal variants
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Lanes 9 and 10 contained respectively, Pst\ and Kpn\ digests of phage lambda DNA. 
Numbers on left of figure denote lambda fragment sizes in kb. Lane 13 (x) contained 
DNA from a non-Lisbon strain MRSA.
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Figure 3.21
Gel photograph show ing Sau3A\ R E FP’s o f Lisbon strain type HI isolates
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Lanes 1 and 2 contained respectively, Kpnl and Pstl digests of phage lambda DNA. 
Numbers on left of figure denote lambda fragment sizes in kb. Isolate AB07 in lane 18 
was a S a u 3 \l  variant.
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3.6 Construction of phylogenetic trees
Figures 3.22 - 3.24 show the three dendrograms obtained. RMS values 
ranged from 8.2 -  9.0. Figure 3.23, the backward run file, was chosen for the 
analysis as it gave the lowest RMS value. In each case MRSA variants from 
the same clonal group clustered together and no close relationships were 
apparent between the different clonal groups. The MSSA formed a number of 
“loose” unrelated clusters with large genetic distances between them. 
Unusually some MSSA appeared to be more distantly related to each other than 
to the single isolate of Staph, hyicus and is probably a result of data saturation. 
Each of the 3 trees indicated that the Lisbon and French strains were very 
closely related.
Essentially, the dendrograms reflected what was shown by the Sd 
analysis of the REFP's, that each MRSA clonal group has diverged little within 
the group but diverged considerably from other MRSA clonal groups, with the 
possible exception of EMRSA-1 and the clonal group endemic to Stobhill 
Hospital during 1993/4.
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3.7 Phenotyping of Staph, aureus strains
(a) Antimicrobial susceptibility testing 
(i) Methicillin-sensitive Staph, aureus
This group of isolates was a heterogeneous collection of strains from 
bovine mastitis, community nasal isolates, GP isolates and isolates from 
nosocomial infections. Most were sensitive to all anti-microbial agents tested 
with the exception of penicillin, to which most isolates were resistant. Several 
strains also showed decreased susceptibility or were fully resistant to 
ciprofloxacin. One bovine MSSA isolate (AB179) was penicillin and 
ciprofloxacin resistant. O f the isolates from nasal carriers, one was 
ciprofloxacin resistant (AB192) and one tetracycline resistant (AB194).
A group of thi'ee MSSA from clinical sites (AB198, 199 and 200) were 
resistant to penicillin, erytliromycin and clindamycin, however, Hhal 
fingerprinting indicated that these were genetically unrelated ( S d = < 85%). 
These results suggested that antibiograms were of little value in differentiation 
among this heterogeneous group of MSSA.
(ii) EMRSA-1
Eight isolates representative of EMRSA-1 that caused outbreaks of 
infection in London and in Brisbane, Australia were studied. These were 
uniformly resistant to penicillin, methicillin, erythromycin, clindamycin, 
tetracycline, trimethoprim, streptomycin and sensitive to fusidic acid, 
ciprofloxacin, mupirocin, chloramphenicol, rifampicin and netilmicin. One of
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the Australian isolates, AB139 was gentamicin resistant and sulphonamide 
sensitive and AB137 differed solely in sulphonamide sensitivity. Isolate 
AB139 lacked a fragment common to all the other EMRSA-1 but it is unlikely 
that this is related to the isolates’ resistance to gentamicin.
Interestingly all the isolates within this small group were trimethoprim 
resistant, which is somewhat unusual among MRSA strains.
(iii) EMRSA-15
The nineteen EMRSA-15 isolates varied little in antibiogram typing. 
Fourteen isolates were resistant to penicillin, methicillin erythromycin and 
ciprofloxacin, and sensitive to clindamycin, fusidic acid, mupirocin, 
tetracycline, chloramphenicol, rifampicin, sulphonamide, trimethoprim and all 
aminoglycosides. Three isolates were erythromycin sensitive (ABI03, 104 and 
111) and all belonged to Hhal variant type 15-HI therefore eiythromycin 
resistance could not be linked to any variation in genotype. Two were sensitive 
to both erythi'omycin and ciprofloxacin (ABIOO and AB114) and belonged to 
the Hhal variant type 15-H2, therefore as ciprofloxacin and erythromycin 
resistance is the normal state for most MRSA, it is possible that lack of 
resistance to both of these agents is coimected to this genotypic variation. Four 
of the five erythromycin-sensitive isolates were from different hospitals.
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(iv) EMRSA-16
All of the seventeen EMRSA-16 isolates were resistant to penicillin, 
methicillin, erythromycin, clindamycin, ciprofloxacin, neomycin and 
kanamycin and sensitive to fusidic acid, tetracycline, chloramphenicol, 
rifampicin, streptomycin, netilmicin and amikacin. Mupirocin resistance was 
detected in nine isolates. High level resistance to mupirocin was not tested for. 
Seven isolates showed combined trimethoprim and gentamicin resistance and 
four of these were also sulphonamide resistant. Sulphonamide resistance was 
also seen in one of the mupirocin resistant isolates.
Kanamycin resistance in EMRSA-16 was interesting. By searching 
results in the database of the Scottish MRSA Reference Lab. (SMRL) it was 
noted that all Scottish EMRSA-16 isolates were kanamycin and tobramycin 
resistant. Although kanamycin resistance was seen in some other isolates in 
combination with gentamicin resistance, very few other isolates were resistant 
to kanamycin and tobramycin together. This suggested that kanamycin 
resistance is a good marker for identification of EMRSA-16, however this 
alone will not differentiate an EMRSA-16 from a Lisbon isolate.
The EMRSA-16 isolates showed a greater degree of variation than 
EMRSA-15 in antibiogram and also at genetic level. None o f the observed 
antibiotic variation could be attributed conclusively to observable changes in 
genotype.
Details of the antibiotic variation seen among EMRSA-16 are shown in 
Table 3.5.
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Table 3.5
Antibiogram  variation detected am ong isolates o f EM R SA-16
Designated
No.
CD MUP SU TM GM
AB119 R S S R RAB120 S S R R RAB121 R s R R RAB122 R s R R RAB123 S s R R RAB124 R s S S SAB125 R R S s SAB126 R R s s sAB127 R s s s sAB128 R R s s sAB129 R R s s sAB130 R R R s sAB131 R R s s sAB132 R S s s sAB133 R R s R RAB134 R R s R RAB135 R R s s s
CD, clindamycin; MUP, mupirocin; SU, sulphamethoxazole; TM, trimethoprim; 
GM, gentamicin.
108
(vj ‘^ Other” MRSA
All of thirty-three (“Stobhill type” plus “Sporadic” group) isolates were 
resistant to penicillin and methicillin and sensitive to chloramphenicol and 
rifampicin. All but one were sensitive to trimethoprim. Two isdlates (AB144 
& AB145) were resistant to all aminoglycosides tested. Both of these isolates 
had identical antiblograms, identical Hhal REFP’s and were isolated at the 
same hospital (RAH). Tetracycline and ciprofloxacin resistance varied 
considerably in this group, nineteen and thirteen isolates were resistant 
respectively. Seven isolates were resistant to fusidic acid. Two isolates 
sensitive to erythromycin were epidemiologically umelated. One isolate was 
mupirocin resistant (AB151). This was isolated from Monklands Hospital and 
was shown by Hhal REFP to be related to the Stobhill MRSA clonal type. 
Antibiogram details of this “non-epidemic” group of MRSA are shown in 
Table 3.6
These results suggest a heterogeneous group of isolates, which confirms 
the results of Hhal genotyping. Overall, antibiogram typing showed each 
epidemic MRSA type had specific traits that could be used to make a 
presumptive identification of the clonal type, e.g. EMRSA-16 were all resistant 
to kanamycin.
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Table 3.6
Antibiogram  variation detected am ong isolates o f “non-epidem ic” M RSA
Designated
No.
ERY FUS CIP MUP TET SU TM NM KM SM GM NET AMI
AB144 R S S s R s s R R R R R R
AB145 R S S s R s s R R R R R R
AB146 R s s s R s s S S s S S s
AB147 R s s s R s s s s s s s s
AB148 R s R s S s s s s s s s s
AB149 R R S s R s s s s s s s s
AB150 R S s s S s s s s s s s s
AB151 R s s R R s s s s s s s s
AB152 R s R S S s s s s s s s s
AB153 R R R s R s s s s s s s s
AB154 R S R s S s s s s s s s s
AB155 R s R s S s s s s s s s s
AB156 R s R s R s s s s s s s s
AB157 R s R s S s s s s s s s s
AB158 R s R s R s s s s s s s s
AB159 R s S s R s s s s s s s s
AB160 R s R s S s s s s s s s s
AB161 R R R s R s s s s s s s s
AB162 R S S s R s s s s s s s s
AB163 R s S s R s s s s s s s s
AB164 R s S s R s s s s s s s s
AB165 R s s s R s s s s s s s s
AB166 R s R s S s s s s s s s s
AB167 R s S s R R s s s s s s s
AB168 R s R s R s s s s s s s s
AB169 R R S s R s s s s s s s s
AB170 R S S s S s s s s s s s s
AB171 R R s s S s s s s s s s s
AB173 R S s s R s s s s s s s s
AB174 R S R s S s R s s s s s s
AB175 S s S s S s s s s s s s s
AB176 R R s s S s s s s s s s s
AB177 S R s s s s s s s s s s s
ERY, erythi'omycin; FUS, fiisidic acid; CIP, ciprofloxacin; MUP, mupirocin; TET, tetracycline; 
SU, sulphamethoxazole; TM, trimethoprim; NM, neomycin; KM, kanamycin; SM, 
sti'eptomycin; GM, gentamicin; NET, netilmicin; AK, amikacin.
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(vi) The “Lisbon strain”
Of ninety-three Lisbon strain isolates, nine antibiogram variants were 
identified. Eighty-four had identical antibiograms. These were uniformly 
resistant to penicillin, methicillin, erythromycin, clindamycin, ciprofloxacin, 
tetracycline, rifampicin, sulphonamide, neomycin, kanamycin, streptomycin, 
gentamicin, netilmicin, amikacin and sensitive to fusidic acid, mupirocin, 
chloramphenicol and trimethoprim.
Of the variants, one had acquired trimethoprim resistance and one 
fusidic acid resistance. Neither isolate was phenotypically distinct by any other 
typing method and both belonged to the dominant Hhal genotype HI.
Six isolates were sensitive to erythromycin and clindamycin and of 
these, four belonged to genotype HI and two to genotype HIO. Five of the six 
were isolated from patients at Glasgow Royal Infirmary and one from a patient 
at Inverclyde Hospital. A single isolate had lost resistance to the 
aminoglycosides gentamicin and netilmicin and this belonged to the unique 
genotype H I3.
Details of the variation in antibiotic susceptibility among the Lisbon 
strain isolates are shown in Table 3.7. As with the other EMRSA groups, 
antibiogram typing alone was shown to be useful for assigning MRSA isolates 
to this clonal group. This was an entirely expected observation since it was by 
this method that the strain was first recognised in Glasgow.
I l l
Table 3.7
Antibiogram  variation detected am ong Lisbon strain M R SA
GENOTYPE Designated No. ERY CD FUS TM GM NET No. of isolates
LISBON H 1 common pattern R R s S R R 84
LISBON H 1 AB14 R R R S R R 1
LISBON H 1 AB35 S S S S R R 1
LISBON H 1 AB43 R R s R R R 1
LISBON H 1 AB55 S S s S R R 1
LISBON H 1 AB56 S S s S R R 1
LISBON H 1 AB57 s s s S R R 1
LISBON H 10 AB88 s s s S R R 1
LISBON H 10 AB89 s s 8 S R R 1
LISBON H 13 AB92 R R S S S S 1
ERY, erythromycin; CD, clindamycin; FUS, fusidic acid; TM, trimethoprim; 
GM, gentamicin; NET, netilmicin.
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(b) B iotyping
(i) Urease Production
All EMRSA-1 and EMRSA-16 isolates tested were mease positive. All 
EMRSA-15 isolates tested were urease negative. Of the “other MRS A” 
isolates, eight of thirty-thi'ee isolates were urease positive.
Among the MS SA isolates, thirty-nine of forty-two isolates were urease 
positive.
Of ninety-three Lisbon isolates all but two were m’ease positive. The 
two negative isolates were otherwise phenotypically and genotypically 
unremarkable.
(it) Hydrolysis o f Tween 80
Five of eight EMRSA-1 isolates hydrolysed Tween 80, as did eighteen 
of nineteen EMRSA-15 isolates and all seventeen EMRSA-16 isolates tested. 
Of the “Other MRS A” group, eight of thirty-three hydrolysed Tween 80 as did 
thirty-seven of forty-two MS SA. Among Lisbon isolates only one of ninety- 
three was found to hydrolyse Tween 80. This isolate was otherwise 
phenotypically and genotypically unremarkable.
As with the urease test these results suggested that within individual 
clones, the Tween 80 reaction remained relatively stable and may be a useful 
strain marker. When results of urease and Tween 80 were combined this gave 
a very useful aid to detection of the most prevalent epidemic strains as 
illustrated in Table 3.8.
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Table 3.8
Use of simple biotype to distinguish between the Lisbon strain and the 
current most prevalent epidemic MRSA strains
TWEEN 80 UREASE
LISBON STRAIN NEGATIVE POSITIVE
EMRSA15 POSITIVE NEGATIVE
EMRSA16 POSITIVE POSITIVE
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(c) Phage typing
The phage typing results were collated together from three separate 
sources and may therefore have been subject to variation in inteipretation.
Phage typing of EMRSA-1 isolates proved problematic. Some isolates 
failed to grow or grew only weakly on phage typing media and phage patterns 
when readable proved confusing with many inhibition reactions. It was 
therefore decided not to include these results in the final analysis. With the 
exception of one isolate, all EMRSA-15 were either non-typeable or typed as 
“75 weak” (75w). One isolate typed as 6w/42E/47w/75w. All EMRSA-16 
isolates typed as 29/52/75/77/83A/83C. The group of thirty-three “Other 
MRSA” isolates showed considerable variation in phage type, although some 
of these types were not distinguishable by definition. The range is illustrated in 
Table 3.9.
Phage typing was not performed on the MSSA isolates.
Among the seventy-eight Lisbon isolates for which phage typing was 
performed, eleven different phage types were identified, although as with the 
“other” MRSA group, some of these were not distinguishable by definition. 
Approximately half of the isolates belonged to phage type 85 or 29/77/84/85. 
The range of phage types is illustrated in Table 3.10.
Although EMRSA-15 isolates fall mainly into two categories when 
phage typed (75w or Non-typeable), non-typability cannot be considered an 
indicator of a possible EMRSA-15 isolate since it is not a positive phenotypic 
trait. However, it may be useful as an aid to identifying isolates of EMRSA-15
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when taken in the context of other phenotyping results e.g. Tween 80 positive, 
urease negative, resistance to; methicillin, erythromycin and ciprofloxacin.
Phage typing was less useM for the Lisbon strain as a number of 
different phage types were recorded.
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Table 3.9
R ange o f phage types found am ong isolates o f “non-epidem ic” M RSA
PHAGE TYPE A/0. OF ISOLATES
85 6
54/85 2
75/85 2
54/85/90 2
6/42E/47/53/54/75/77 2
85/90 1
42E/47/53/54/75/77 1
6/47/54/75/81 1
6/47/54/75/81/85 1
54/77/47/81 1
53 1
53/85 1
53/85/88A 1
53/83A/75/88A 1
54 1
54/84 1
NT 6
ND 2
NT : Not typeable, ND: Not Done
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Table 3.10
Range o f phage types found am ong Lisbon strain isolates.
PHAGE TYPE No. OF ISOLATES
29/77/84/85 22
85 21
77/84 9
77/84/85 8
54/77/84/85 5
54/75/84/85 3
77 2
75 1
54 1
84/85 1
54/77/84/85/75 1
NT 4
ND 15
NT: Not typeable, ND: Not done
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Summary of phenotyping results
Table 3.11 summaiises the phenotypic typing of the study isolates when 
broken down into their individual groups. It is noteworthy that all MRSA 
clonal groups fell into distinct groups on the basis of Tween 80 and urease 
reactions and although EMRSA-1 and 16 isolates were positive for both tests, 
inclusion of the antibiogram type enabled further discrimination of these two 
strains.
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Table 3.11
Sum m ary o f phenotyping results
STRAIN UREASE TWEEN PHAGE
POSITIVE POSITIVE TYPE^
RESISTANP
LISBON
EMRSA1
EMRSA15
EMRSA16
STOBHILL
MRSA
OTHER
MRSA
MSSA
91/93 1/93
8/8 6/8
0/19 18/19
17/17 17/17
1/25 2/25
8/8 7/8
17/17 12/17
29/77/84/85
54/77/84/85
ND
75w
29/52/83A/
75/77/83A
6/42E/47/54/75/85
6/42E/47/53/54/75/77
42E/47/53/54/75/77,
54/77/47/81
53/83A/75/88A
NT( 2 )
N D ( 2 )
ND
MET,ERY,CD,CIP
TET,RIF,SU.
AGL
MET.ERY.GD.TET 
TM.SU.SM 
MET.ERY.CIP 
MET.ERY, CIP NM, 
KM, CD (15/17) 
MUP(9/17)
MET, ERY 
TET( 16/25)
MET, ERY (4/6)
PEN (16/17) 
ERY (3/17) 
CIP (2/17) 
TET(1/17)
' Not all patterns listed
 ^Abbreviations defined in methods, except AGL: all aminoglycosides 
NT: Not typeable, ND: Not done
1 2 0
.
1 2 1
.  % i
Electrophoresis following whole cell DNA digestion with frequent 
cutting restriction enzymes is a technique that has not been widely used. In 
instances where it has been used, the enzymes have been six base cutters and 
the choice of enzyme and electrophoresis conditions has been optimal for the 
resolution of fragments less than 6kb (six base cutters). Jordens and Hall 
(1988) used Bglil (recognition sequence, AGATCT) to type epidemic MRSA 
isolates from the Thames region and although they were able to say that the 
epidemic isolates had similar REFP’s and unrelated MRSA and MSSA isolates 
had different REFP’s, the interpretation of these REFP’s appeared to be very 
difficult from the figures shown and it is doubtful if the technique would have 
allowed any form of computerised comparison of REFP’s. In addition, 
fragments due to plasmid DNA also caused problems with interpretation. In a 
later study of Chinese MRSA by the same authors (Hall and Jordens 1989), a 
similar technique highlighted the presence of an endemic MRSA strain in one 
hospital while in a second hospital the isolates were of a more heterogeneous 
nature. Dice coefficients were used in the Chinese study to determine 
relationships between isolates. As is also applicable with this study, when 
using Sd analyses to compaie isolates it is important to emphasise that it is the 
similarity of the banding pattern that is being compared, reflecting conservation 
of restriction sites in the genome. It must be borne in mind that matching 
fragments do not necessarily mean identical fragments, as two similar sized 
DNA fragments may have quite different nucleotide sequences.
Hhal and SauSAl, used in this study are four base cutters (recognition 
sequences GCGC and GATC respectively) which had the advantage of
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resolving larger DNA fragments. The resolution of larger fragments obtained 
after Hhal digestion and electrophoresis additionally provided a degree of 
visual quality control, in that partial digestion products were recognisable if 
present. In addition, the technique overcomes many of the limitations 
described by Owen (1989).
Resolution of large fragments provides an open analytical window
amenable to computerisation and thereby allowing gel to gel comparisons. It
can be adapted to a wide range of disparate organisms using a primary
screening panel of usually eight enzymes. The main disadvantage of the
technique is that a relatively small portion of the genome is compared and thus
different enzymes may not be concordant. The presence of plasmid DNA can
on occasion complicate REFP interpretation but any such problems can usually
be resolved by running purified plasmid DNA digested by the same enzyme in
.the well adjacent to the genomic digest (Platt et a l, 1996). In addition, within 
this study, experience has indicated that plasmid fragments in a genomic REFP 
are generally present in higher copy numbers, tend to stain with greater 
intensity than genomic fragments and are readily recognised visually.
A selection of epidemiologically unrelated MSSA & MRSA were
chosen as control groups in order to evaluate the discriminatory power of the
.restriction enzymes Hhal and Sau3Al to distinguish both between and within 
different MRSA strains involved in outbreaks of infection, as a prelude to the 
detailed investigation of the Lisbon MRSA strain. All strains within a single 
bacterial species must have a significant amount of DNA sequence in common 
to be identified to this taxonomic level. It is possible that any given enzyme
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will generate analysable fragments from the conserved (species specific) DNA. 
Such enzymes would have little resolving power and could not be used to infer 
that identical REFP’s of outbreak strains was meaningful. Conversely, where 
epidemiologically unrelated strains are shown to be distinct, the subsequent 
demonstration of identity among potential outbreak strains could be taken as 
evidence to infer close genetic relatedness.
MSSA strains have been undergoing divergent evolution for countless 
numbers of years therefore a large number of polymorphisms should be 
expected. It follows therefore, that epidemiologically unrelated isolates of 
MSSA will have considerable variation in the arrangement of their genomic 
DNA and that this variation can be detected by evidence of RFLP's in their 
genomic fingerprints. Conversely, MRSA strains have evolved over a much 
shorter time scale (less than 40 years) and therefore it was expected that their 
genomic fingerprints would be less diverse, especially if the theory put fomard
by Kreiswirth et a/. (1993), that the acquisition of mec by Staph, aureus was a 
unique event and that all modern MRSA strains are derivatives of this single 
clone, is correct.
Using probes derived from mec A  and Tn554 to hybridise to Clal 
genomic digests of 472 MRSA isolates dating from the earliest isolations in 
1961 to early 1990's, Kreiswirth and co-workers found six mec A  polymorphic 
types, which could be arranged chronologically, and 29 different Tn554 types. 
They also found that with only one exception (a type showing no homology 
with Tn55V) each Jn554 type occurred in combination with one and only one 
mecA pattern suggesting that primary differentiation of mecA patterns is
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followed by independent evolution of the TnJiV patterns within each mecA 
family. Their overall results tended to suggest that horizontal transfer of mec A  
after its initial establishment in Staph, aureus is extremely rare and that mec A  
may have been acquired by Staph, aureus on a single occasion. However, one 
major criticism of this study must be the use of two markers not found normally 
in strains of MSSA. To give the study more validity it would have been useful 
to include the evolution of a suitable marker found in both groups of Staph, 
aureus. Alternatively, Musser and Kapur (1992) used MLEE on a collection of 
254 MRSA isolated over a similar time span but not matched to that of 
Kreiswirth. They found fifteen distinctive electrophoretic types, marking 
clones and that the mec gene was harboured by many divergent phylogenetic 
lineages representing a large portion of the breadth of chromosomal diversity 
within Staph, aureus. This result was interpreted as evidence that the 
horizontal transmission of mec A  had occurred and therefore a number of 
unrelated MRSA clones exist. In addition, they also found that MRSA isolated 
soon after introduction of methicillin into clinical use in the 1960's from the 
UK, Denmark, Switzerland, Uganda and Egypt belonged to a single 
electrophoretic type (clone) and concurred with the hypothesis of Lacey and 
Grinstead (1973) that European MRSA recovered in the 1960's and early 1970's 
are the progeny of a single ancestral cell which acquired the mec determinant.
Mussers study although convincing must be criticised for the small 
number of enzymes tested, they presented no analysis to demonstrate linkage 
disequilibrium and genetic drift was not excluded.
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The findings of studies by Dominguez et.al (1994) and Couto ei. al 
(1995) using mec A  hybridisation and PFGE also suggest the possibility of 
horizontal transmission of mec (see below). Given the diversity indicated by 
Hhal genomic REFP's between the Lisbon strain and the EMRSA-1, 15 and 16 
strains, these results would perhaps seem to favour Musser's hypothesis as they 
are so divergent that their independent evolution from a single clone seems 
unlikely. However, the fact that the technique only examines a small 
proportion of the genome must be taken into consideration and such 
conclusions can be dangerous when only a single molecular typing method is 
used. In other words, the Hhal teclmique does not yield enough evidence to 
back up or disprove either authors hypothesis. Specifically the Hhal technique 
demonstrates minor variations and allows similarity to be detected over short 
time spans. A given Hhal REFP does not contain sufficient information to 
maintain the demonstration of similarity over longer time periods due to the 
occurrence of data saturation.
Since this original work of Kreiswirth, several workers have carried out 
epidemiological investigations on the spread of MRSA using Smal PFGE in 
combination with mecA and Tn554 probe hybridisation of Clal chromosomal 
digests. Tn554 was originally chosen to provide a higher degree of resolution 
when used in combination with the mec A  hybridisation data. It occurs with a 
frequency of >90% among MRSA isolates, has never been found on a plasmid, 
is highly specific in its attachment sites and is often present in two or more 
copies. It contains a single internal restriction site for Clal, therefore a single 
insertion of the transposon is represented by two hybridising bands.
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reasons that some reference laboratories including CDC in Atlanta have now 
abandoned phage typing in favour of PFGE as their main typing system for 
epidemiological investigations of Staph, aureus.
m
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•" />A genotyping system based on defined chromosomally located variable 
genetic elements has significant advantages over phenotypic systems such as 
phage typing, antibiogram, and biotyping because the genetic basis of the 
phenotypic variability is usually unknown and the observed phenotypic 
variation can often be due to more than one type of genetic event.
Phage typing of staphylococci for example, lacks a systematic 
biological basis, is plagued by non-typeable isolates and by unpredictable 
variability among typeable ones (Bannerman et. al, 1995). It is for such
The Kreiswirth approach has been used in a number of MRSA 
investigations and in particular in tracing the spread of the Iberian clone to
’which the Lisbon strain is closely related. Couto and co-workers (1995) used 
in addition to standard phenotyping methods, a combination of PFGE, Tn554 
and mec A  typing to characterise MRSA and MSSA strains collected over a 3 
month period in 1993 from a single Portuguese hospital. Their findings 
suggested that an unusually large number of MRSA clones were present in the 
hospital at this time (24 different PFGE types among 54 clinical isolates). This 
led to the suggestion that the hospital had been acting as a reservoir for strains 
(including the Iberian clone) responsible for outbreaks in other parts of 
Portugal and Spain.
Their results also indicated a limited clonality of mecA in that only 3 
CW-mecA types were found in contrast to the six described previously by
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Ki'eiswirth et a l (1993); mec A  polymorphs I-VI, and the five described by 
Dominguez et al (1994); mec A  polymorphs VII-XI. In common with 
Dominguez, they found that Tn55V types could be associated with more than 
one mec A  polymorph, contrary to the findings of Kreiswirth. The findings that 
the same mecA polymorph can be associated with numerous chromosomal 
backgrounds as represented by PFGE patterns and that more than one, of 
previously established mecA polymorphs, can be associated with the same 
PFGE type was also suggestive of the possible horizontal transfer of mecA.
In the same study, Dominguez et al. applied Dice coefficients to PFGE 
patterns and found Sd values of 68% between major PFGE types and Sd values 
of >88% among sub-types, a result which closely parallels the findings of this 
study using Hhal. Another interesting finding of Dominguez was the isolation 
of MSSA and MRSA isolates with closely related PFGE patterns from the 
same patient. The PFGE patterns differed only in the fragment carrying mec 
DNA. The patterns suggested a deletion of the mec region resulting in an 
MSSA homolog.
As far as this author is aware, this is the only epidemiological study of 
MRSA using restriction enzymes that recognise 4 base sequences (frequent 
cutters). The results of this study suggested the technique may have 
considerable potential in future investigations of this type since it 
unequivocally placed all the control MRSA and Lisbon isolates into distinct 
clonal groups in agreement with phenotyping results while showing a greater 
diversity among the MSSA isolates. In addition the technique was further able 
to discriminate sub-types within each clonal group thus allowing a possible
— —   — —
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evolutionary sequence to be proposed since the arrival of the Lisbon strain in 
Scotland (Figure 3.18). Whereas the combined genetic techniques as described 
above undoubtedly provide a greater depth of epidemiological and evolutionary 
data, the Hhal technique has the advantage of being simple, cost effective and 
probably within the scope of most routine clinical laboratories with basic 
equipment. It also has more than enough resolving power to type outbreaks at a 
local level. Ideally, within the context of an outbreak the chosen technique 
should identify all outbreak isolates as identical or closely related while 
eliminating all unrelated isolates. The Hhal technique has been shown to fulfil 
these criteria within the confines of the study. Whereas it was thought initially 
that the French MRSA was a different strain on the basis of phenotypic tests, 
genotyping with Hhal combined with Dice coefficient analysis showed these 
isolates to belong to the same clonal lineage as the Lisbon strain.
Although the MSSA isolates were epidemiologically unrelated, the fact 
that they came from within a relatively small geographical area may have 
contributed to slightly higher Sd values than expected. The phenotypic tests 
were of little value in typing the MSSA isolates, as they were for the most part 
susceptible to most antibiotics with the exception of penicillin and 
ciprofloxacin to which most isolates were resistant. The high usage of 4- 
fluoroquinolones since their introduction has led to this valuable drug being 
mostly ineffective for nosocomially acquired Staph, aureus infection. As most 
isolates were positive for both Tween 80 hydrolysis and urease production, 
simple biotyping alone or in conjunction with antibiogram could not be used to 
produce a useful typing scheme for these isolates. However, as most isolates t
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conformed to a single biotype (penicillin and ciprofloxacin resistant. Tween 80 
hydrolysis and urease positive) unusual isolates not conforming to this biotype 
could be easily recognised.
Within each epidemic MRSA control group high levels of similarity 
were found, with mean Sd values >90%. From these results an estimate was 
made of around >85% for the predicted Sd value which would assign isolates 
to a defined clonal lineage. These isolates had been designated a particular 
epidemic type previously on a phenotypic basis (EMRSA-1 etc.) and it was 
unknown how genetically similar they would be to each other within their 
groups and also between groups.
The epidemic MRSA control groups were selected as belonging to a 
specific epidemic type based on phenotypic criteria (phage type), and at the 
time of their selection the genetic relationships between isolates within the 
same epidemic type was unknown.
EMRSA-1
In 1984 this became the first recognised epidemic strain to be described 
in the UK (Cookson and Phillips, 1988). The phage-type of the strain at 
RTDIOO was 85 and varied to some extent with 83A and 84 and with 
experimental phages 88A and 932. Although phage typing of the EMRSA-1 
isolates in this study was attempted, the results repeatedly gave a confusing 
array of mixed reactions and therefore the data was not used.
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Just as Hhal had demonstrated its ability to discriminate among 
unrelated strains of MSSA, its ability to recognise genetically related strains 
was evident with this group of MRSA. Minimal difference was seen between 
isolates’ overall REFP’s although on the basis of individual fragment 
differences Hhal was able to subdivide the group into 5 sub-types.
REFP analysis of the EMRSA-1 isolates revealed the three London 
isolates to be very closely related (a single fragment difference) and slightly 
more variation was seen between these and Australian isolates. The divergence 
seen between these two sub-groups probably resulted from different 
environmental selective pressures. The Hhal REFP's of these isolates indicated 
that they belonged to the same clonal lineage.
When the REFP from the commonest subtype was matched with the 
MSSA group, an Sd value of 85% resulted between this and AB198, a 
community nasal isolate. However when the fragment size variation of 5% was 
reduced to 1% the Sd value dropped to 46% which agreed with the result when 
the fragments were matched visually and Dice coefficients calculated manually. 
This indicated that the computer is less sensitive than the eye and highlighted 
the importance of taking visual analysis of the gel into consideration when 
interpreting REFP’s as the epidemiological data suggested that both these 
isolates were urn elated.
The fact that the EMRSA-1 isolates were all sensitive to ciprofloxacin 
distinguished this group from the other EMRSA groups in the study which 
were resistant with very few exceptions. That all the EMRSA-1 isolates were 
sensitive to ciprofloxacin may be a throwback to the age of this strain; i.e. it
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may have evolved to epidemic status and later lost its environmental niche to 
other more persistent MRSA lineages before ciprofloxacin became such a 
widely used agent for staphylococcal infections. Ciprofloxacin was not 
introduced into clinical practice until the late 1980's, therefore this observation 
is not surprising given that resistance to this agent has arisen in staphylococci 
as a result of widespread use, particularly in treatment of MRSA infections. A 
uniform resistance to tetracycline was seen among the isolates of this group.
This was also the case among Lisbon strain isolates and a high proportion of 
the non-epidemic MRSA. Prior to the appearance of the Lisbon strain in 
Glasgow, tetracycline resistance among MRSA was also high and probably Ireflected a high usage of this antibiotic for staphylococcal infection (G.
Edwards, personal communication). The fact that the latest epidemic MRSA 
strains (EMRSA-15 & 16) are generally sensitive to this agent may reflect a 
decline in its usage. EMRSA-1 is now only occasionally seen in the UK and 
data from the Scottish MRSA Reference Laboratory (SMRL) suggest that 
EMRSA-1 is not seen in Scotland. Statistics provided by the SMRL from April 
1997 to July 1998 suggest trimethoprim resistance among Scottish MRSA is 
relatively rare. Among 4267 isolates of EMRSA-15 only 0.33% were resistant 
to trimethoprim (14 isolates) and of 934 isolates of EMRSA-16 only 2.67% 
were resistant. Of a total of 5719 MRSA isolates received in this time only 
3.5% exhibited resistance to trimethoprim.
The emergence of multi-resistant strains of staphylococci in the 1970’s 
is thought to have resulted by the combination of resistance genes with 
transposable elements (Lyon and Skurray, 1987). The mobility of transposable
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elements enabled firstly the accumulation of resistance determinants on 
plasmids (which can then disseminate resistance to large numbers of 
antimicrobial agents through the bacterial population) and secondly, these 
elements can then transpose to the chromosome.
Conjugative plasmids clearly demonstrate the role played by 
transposable elements in the evolution of multi-resistance plasmids. The pSK4 
plasmids (3 5kb) can carry up to 3 different transposons -  Tn4001, which 
cames resistance determinants to gentamicin, tobramycin and kanamycin, 
Tn4003 (trimethoprim resistance) and Tn4002 (penicillin resistance). Most of 
this plasmid family also carries additional resistance determinants to antiseptics 
and disinfectants.
The rapid rise in isolations of EMRSA-15 and 16 since 1993 (CDR 
weekly Report, January, 1993) has seen a concurrent decline in isolations of all 
other epidemic MRSA strains including Lisbon. Reasons for the continued rise 
of these two epidemic types are unclear but may be due to an increased ability 
to colonise skin and mucous membranes.
EMRSA-15
Having shown that Hhal could successfully differentiate among 
unrelated strains of Staph, aureus and also detect genetically similar or 
identical isolates, the enzyme showed that phenotypically related isolates of 
EMRSA-15 were also genetically very similar. Of nineteen EMRSA-15 
isolates, three genomic variants were found (when the large plasmid fragment 
was discounted), of 16 (type E15H1), 2 (type E15H2) and one isolate (type
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E15H3). The two E15H2 variants (ABIOO, AB114) were both sensitive to
.erythromycin and ciprofloxacin. These isolates were from Dumfries and the 
Vale of Leven respectively. Data from SMRL indicated that of 4267 EMRSA- 
15 received from April 1997 to July 3fr  ^ 1998, only 12 were susceptible to both 
these antibiotics. Most of these 12 were also atypical in other respects such as 
phage type and PFGE type.
Erythromycin resistance in MRSA is generally associated with
possession of the transposable elephant Tn554 (Phillips and Novick, 1974).
Tn554, a site-specific transposon, carries the gene ermA that encodes inducible
resistance to the macrolide lincosamide and streptogramin B (MLS) groups of
antibiotics (Weisblum and Demohn, 1969). It also contains the spectinomycin
resistance gene spc. Tn554 is unusual in having a high specificity for a primary
.chromosomal attachment site (att55A). Tillotson et al. (1989) showed that in 
contrast to earlier results showing extreme site specificity for the transposon 
(Murphy et al., 1981; Phillips and Noviek, 1979), many isolates of Staph, 
aureus contained second inserts at secondary sites on the clrromosome. They 
found that an attachment site for secondary Tn554 insertion {att\55) is within 
or very close to the region of mec DNA on the staphylococcal clrromosome. A 
number of different classes of Tn554 insertions were found with class 1 being 
the classical primary insertion site and the novel insert in MRSA being f|
designated class 6. This class 6 insert was found in all of 29 MRSA examined 
but not in any MSSA. Their results suggested an association of the attlSS 
region with the mec associated DNA but they were unable to provide any direct 
evidence for this. Current figures of erythromycin resistance in MRSA
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certainly suggest a strong correlation of erythromycin resistance with 
methicillin resistance while among MSSA, erythromycin resistance remains at 
a much lower frequency.
Erythromycin sensitivity is therefore most likely due to lack of an active 
copy of Tn55V or possession of an inactive form. This is easily tested for using 
a DNA hybridisation protocol and such a test forms the basis of a now 
commonly used typing scheme for MRSA (Kreiswirth et al., 1993; De 
Lancastre et al., 1994; De Sousa et al., 1996; Mato et al., 1998). PCR 
protocols may also be used to detect Tn554 (Platt and Parsons, unpublished 
data). Although five eiytliromycin-sensitive EMRSA-15 were found in the 
study, no obvious epidemiological link could be established.
Isolate AB114 also had an unusual phage type (6w/42E/47w/75w) 
which had not been seen among other EMRSA-15 sent to SMRL. Since most 
EMRSA-15 are either non-typeable or type as 75w this was regarded as an 
unusual phenotype. It is intended to investigate these observations further with 
the help of the SMRL. Isolate AB114 also harboured a unique plasmid of 
12kb. ABIOO was found to be plasmid free and with the exception of ABl 14, 
all other EMRSA-15 contained either a 3.8kb or 38kb plasmid or both (plasmid 
data not shown). An investigation of the role of these plasmids and their 
relationships if any, to other MRSA plasmids may provide scope for further 
investigations.
Prior to Hhal typing, these two isolates had not been recognised as 
EMRSA-15's and were originally included in the sporadic MRSA group. This 
further illustrates the unreliability of phenotyping. Had Hhal genotyping been
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available at the time of their initial characterisation, these isolates would have 
been clearly recognised as EMRSA-15, The establishment of detailed accurate 
epidemiological information is important as it distinguishes the potentially 
more troublesome epidemic strains from sporadic MRSA isolates. This 
information may be important to infection control teams as the appropriate 
action taken when an MRSA is identified may vary depending on whether or 
not it is an epidemic strain.
The Hhal REFP's of these two isolates were identical to the 
predominant type except that a fragment of 9.0kb (Figure 3.6) replaced the 
8.9kb fragment common to the other EMRSA-15’s. This may have been due to 
the loss of a restriction site in the 8.9kb fragment. If the 8.9kb fragment 
contained a Tn55V copy, an insertion into this gene could have rendered the 
gene inactive to result in the loss of erythromycin resistance. The unique phage 
type of ABl 14 may be related to its possession of a 12kb plasmid. Curing the 
isolate of the plasmid and re-testing the phage type would help to confirm this.
Given the number of both phenotypic and genotypic differences found 
between these two isolates and the other EMRSA-15, it is also possible that 
these isolates are more distantly related to EMRSA-15 than the Hhal REFP's 
suggest. Typing anomalies such as this can be resolved in some cases by use of 
a second enzyme. As the Sau3A digests in Figure 3.15 showed, isolate ABl 14 
in track 10 gave a considerably different REFP to the other EMRSA-15 in track 
11. This result is in conflict with the Hhal result. When use of a second 
enzyme fails to resolve an anomaly then the application of a different molecular 
typing technique is the next step. In this instance PFGE may provide the
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necessaiy discrimination to confirm or refute that these isolates belong to the 
EMRSA-15 clonal type.
The other genomic variant, ABl 10 (E15H3) differed from the 
predominant type in possessing an additional fragment of approximately 
11.6kb. Since the technique examines only a small proportion of the entire 
genome we can only speculate how this variant arose. Such a large fragment is 
unlikely to have arisen fiom the loss of a single restriction site without a 
noticeable change elsewhere in the REFP pattern. A more likely explanation is 
that the isolate has gained this extra DNA fiom an event such as the integration 
of an insertion sequence, transposon or phage into the genome. No unusual 
phenotypic traits (such as additional antibiotic resistance) were observed with 
this isolate which may have indicated the integration of an insertion sequence 
or transposon. Although Hhal genomic REFP's identified all these isolates as 
belonging to the same clonal lineage, further work will be necessary to 
establish the detailed genomic relationships between isolates ABIOO and 114 
and typical EMRSA-15's.
The EMRSA-15 Hhal genomic REFP was very different from that of 
the EMRSA-1 both visually and by computer analysis of So values. This could 
perhaps be interpreted as an indication that they have evolved independently 
from unrelated MRSA ancestors. Alternatively, if the clonal theory of MRSA 
evolution is correct and all modern day MRSA have evolved from a single 
clone, then it may indicate that the two strains have diverged and evolved from 
the archetypal MRSA at a very early stage in their evolution. If the strains had 
begun to diverge sufficiently long ago, because of the large number of
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mutations or rearrangements that could have occuiTcd within restriction sites 
data saturation can occur which obscures the genetic relationships between the 
strains. However on the basis of Hhal REFP’s alone there is insufficient 
evidence for such speculation.
As with EMRSA-1, Hhal identified minor genetic variations among the 
group. Other genetic typing schemes can also subtype these epidemic strains 
and at this stage it is not yet known how the Hhal type / subtype correlates with 
these, e.g. PFGE. A comparative study of Hhal typing versus PFGE may be 
the focus for future work as the two systems may compliment one another by 
helping to resolve anomalies seen when only one system is used.
For reasons as yet unknown, antibiogram results proved EMRSA-15 to 
be the least resistant MRS A type. EMRSA-15 may have evolved fairly recently 
(first recognised in 1991) from the horizontal transfer of mec into a fully 
sensitive MS SA. In which case it may not have had enough time to acquire 
new resistance determinants; or it may lack some genetic mechanism required 
for the establishment of new resistance traits whether they be plasmid encoded 
or on mobile genetic elements.
Outbreaks of EMRSA-15 infection were confirmed at Stobhill Hospital 
and Glasgow Royal Infirmary by application of this technique. Disruption to 
the routine work of the laboratory was minimal, illustrating that the technique 
can be adapted to use in a clinical setting in addition to being a valuable 
reseai'ch tool.
In the UK, successful infection control measures rely on ensuring 
stringent hand washing between handling patients and isolation of patients,
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rather than antibiotic usage. This move away from antibiotic usage may in part 
be responsible for the evolution of MRSA which are less multi-resistant. If 
there is no selective pressure on the organisms, unnecessary resistance traits 
will be lost to allow the organism to adapt to its new environment and become 
genetically more fit. In Southern Europe infection control policies tend to be 
less aggressive and antibiotic usage is high, hi addition, antibiotics are freely 
available over the counter. These factors may contribute to the predominance 
of multi-resistant MRSA clones such as Lisbon (Iberian clone). Data from the 
SMRL is in agreement with this observation that EMRSA-I5 is not a multi- 
resistant MRSA.
The lack of urease activity amongst EMRSA-15 isolates appeared to be 
an important phenotypic marker because, with the exception of the “Stobhill 
clone” of MRSA the vast majority of Staph, aureus isolates were urease 
positive. Although this trait when considered alone is of little value in 
assigning an organism to a particular type, when used in conjunction with other 
tests such as Tween 80 hydrolysis and antibiogram, most isolates of EMRSA- 
15, EMRSA-16 and “Lisbon” can be distinguished presumptively.
EMRSA-15 although the predominant strain isolated in the UK at 
present, is generally regarded as less pathogenic than EMRSA-16, being more 
commonly associated with colonisation than true infection, however it is 
difficult to obtain evidence to support such claims.
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Hhal divided the EMRSA-16's into 5 subtypes. Some REFP's 
contained fragments suggestive of plasmid DNA. All isolates which were 
resistant to gentamicin and trimethoprim showed these fragments but plasmid 
profiling and plasmid REFP's (twice) failed to demonstrate any evidence for 
these being plasmid in origin. It is possible that these fragments may have been 
pait of a transposon that harboured both resistant determinants.
The mean Sd values between EMRSA-16's, EMRSA-15's and EMRSA- 
1 showed that Hhal was very successful in assigning these epidemic strains to a 
specific lineage and at distinguishing between different epidemic clones 
(Tables 3.3 and 3.4).
As with EMRSA-1 and 15, isolates in this group were also genetically 
closely related by virtue of their Hhal REFP’s. Genetic variation within the 
strain appeared to be related to isolate location with type E16H2 found 
exclusively at the Western General Hospital, Edinburgh; type E16H3 found at 
Monklands Hospital; types E16H4 and E16H5 found at HCI Hospital and one 
E16H4 variant was also found at Stobhill Hospital. Differing geographic 
locations may be an important factor in the molecular divergence of MRSA as 
the organisms are subjected to different selective pressures. This geographic 
factor was also evident when the variation of the Australian EMRSA-1 was 
compared to that of the English isolates and illustrates that the technique may 
be useful in the recognition of endemic strains that have diverged.
140
Additionally, resistance to clindamycin and kanamycin was expressed 
by all the EMRSA-16 isolates and these appear to be key markers in the early 
recognition of this clonal group.
This was the only group in which mupirocin resistance was seen. 
Mupirocin resistance in staphylococci is either high-level (>256mg/L) or low- 
level (0.5 -  256mg/L) which is more common (Rahman et a l, 1987; Baird and 
Coia 1987). Mupirocin is an inhibitor of isoleucine tRNA synthetase and low- 
level resistance was shown to result from a chromosomal mutation and 
produced an altered enzyme that had a reduced affinity for mupirocin. In 
contrast, high-level resistance is plasmid mediated by the mupK gene (Gilbart 
et a l, 1993). This gene is sometimes flanked by copies of IS257, which 
suggests that the gene can be mobilised. The mechanism of resistance in these 
isolates was not elucidated at the time of the study therefore it was not known if 
the mupirocin resistance was due to high or low level resistance, however this 
will be addressed in future work with the assistance of SMRL.
Although use of mupirocin for the eradication of MRSA colonisation is 
widespread and common, the incidence of resistance among Scottish MRSA 
isolates remains low. Among the isolates which have been found to be 
mupirocin resistant, high level resistance is rare. Of the epidemic strains 
(EMRSA-15, 16 and Lisbon) resistance is greatest in EMRSA-16 but the 
frequency of resistance is greatest in the non-epidemic MRSA (data supplied by 
SMRL).
The isolates from Dumfries showed combined resistance to gentamicin, 
kanamycin and trimethoprim. Although we were unable to demonstrate
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presence of any plasmid in these isolates, a likely explanation for this resistance 
is the presence of a large conjugative plasmid. Almost all conjugative plasmids 
encode resistance to gentamicin, kanamycin and tobramycin by virtue of 
production of a bi-functional 6’ acetyltransferase/2” phosphotransferase. 
These plasmids can also mediate resistance to ethidium bromide and quaternary 
ammonium compounds (Lyon and Skurray, 1987). Some of these plasmids 
(pSKl) also cany the trimethoprim resistance transposon Tn4003 on which is 
located the gene for a type SI DHFR (dihydrofolate reductase). It is possible 
that transposition of Tr\.4005 to the chromosome has occuiTcd in the above 
isolates.
Kanamycin resistance appears to be a very good strain marker for 
EMRSA-16. Among the Scottish MRSA where kanamycin resistance occui’s in 
absence of gentamicin and netilmicin resistance, the isolate is almost always an 
EMRSA-16. This resistance mai'ker in conjunction with a simple biotype 
(tween/urease) is a very accurate phenotypic indicator of this strain type 
(although many English EMRSA-16 are gentamicin resistant). All isolates 
tested in the study were positive for both urease production and Tween 80 
hydrolysis. Figures from SMRL indicate that this is also the case on a larger 
scale. Of 925 isolates of EMRSA-16 sent to SMRL between April 1997 and 
July 1998, only 6 were urease negative. The preliminary identification of 
epidemic strains in this manner provides useful information allowing prompt 
infection control measures to be implemented while detailed typing at a 
molecular level is carried out.
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O ther M R SA
Hhal fingerprinting among the mixed group of MRSA highlighted the 
possible existence of another clonal group, which may be epidemic in nature as 
it was isolated from a number of unrelated sources. Since the majority of these 
isolates came from Stobhill it was tentatively named the “Stobhill clone”. 
There did appear to be more variation between REFP's of this group as shown 
by the wider range of Sd values (76-100%, mean 89%). Again, some of these 
REFP's were complicated by the presence of plasmid DNA fragments that 
contributed to the variation seen. As previously mentioned, for optimum 
interpretation of the genomic REFP's it is probably advisable to run genomic 
digests in parallel with their corresponding plasmid digests on the same gel. 
This approach although more time consuming can yield a large amount of 
useful genetic information and provides understanding beyond minimalist 
epidemiology. If necessary an attempt can be made to cure isolates of plasmid 
DNA using growth in novobiocin at 42°C, however the success rate of this 
approach is varied. Alternatively, the use of a second enzyme may have 
confirmed these isolates as a distinct clonal group.
This would be another interesting group to type by other molecular 
methods as a combination of methods may help confirm the clonal status of the 
group.
By performing PFGE on the isolates they can be matched to PFGE 
patterns held on computer at SMRL, which should give some indication if the 
strain was detected within the last 18 months. It may be that the highly 
successful EMRSA-15, which had not yet reached its epidemic height in
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Scotland ai'ound 1994/5, has now displaced this strain from the ecological 
niche it previously occupied. A comparison of Sd values of this group with the 
other epidemic strains also indicated that it was not related to the EMRSA-1, 
15, 16 or Lisbon clones. These results confirm that the technique is both 
sensitive and specific at detecting individual MRSA clones.
As expected, the Hhal REFP's showed MS SA to be more diverse than 
their MRSA counterparts, since in evolutionary terms MSSA have been 
evolving for countless numbers of years as opposed to the near 40 years for 
MRSA.
Sau3A\ typing
Initial results with Sau3Al were limited. It was found to be less 
discriminating than Hhal only recognising 7 Lisbon variants. This fact is not 
necessarily a disadvantage as it provides a hierarchical structure, which 
enhances the overall information obtained.
Sau3Al digested the staphylococcal DNA into much smaller fragments 
(suggesting a far greater number of restriction sites) resulting in fewer 
discernible bands amenable to computer analysis. Because of the poor 
preliminary results coupled with the high cost of this enzyme only selected 
isolates were typed. Typing systems based on results of single enzyme digests 
can be less reliable than when two enzymes are used.
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Use of the technique in a clinical setting
The technique was found to be useful in the investigation of a small 
cluster of five MSSA bacteraemia's which were thought to be related, within 
the Coronary Care Unit at Stobhill. Although the isolates were phenotypically 
indistinguishable, genomic fingerprinting with Hhal and Sau3Al proved them 
all to be unrelated. This served as a useful reminder that the technique can be 
used effectively in epidemiological investigations not only for MRSA but also 
for outbreaks involving MSSA isolates that may be difficult to type by 
phenotypic methods. In a veterinary setting the technique has been used in the 
investigations of bovine S. aureus, S. hyicus and S. intermedius (Platt et al., 
1994).
Technical aspects of Hha\ genomic fingerprinting
Using the protocol as described in the Materials and Methods section it 
took approximately 3 - 4  days to type an isolate starting with an isolated colony 
on a blood agar plate. If using the technique to type isolates in an ongoing 
outbreak this could be seen as a major disadvantage, however in a setting where 
the technique is used to type a large collection of isolates in a retrospective 
analysis the time factor is less important. In addition, during an ongoing 
outbreak, more rapid PCR protocols may provide sufficient resolving power for 
preliminary results and Hhal fingerprinting can provide a degree of fine-tuning 
to the investigation.
The DNA extraction method used was a disadvantage. It was labour 
intensive and involved the toxic chemicals phenol and chloroform. One
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potential solution is adaptation of commercially available rapid genomic DNA 
extraction kits; optimally the protocol would provide purified DNA in one day. 
However, preliminary personal experience of this approach produced 
disappointing results with DNA yields being consistently low (data not shown). 
In contrast to this, a benefit of the study extraction protocol was that it gave 
high yields of DNA sufficient for up to 3 enzyme digests.
The MSSA group chosen as controls ranged in similarity coefficients 
from 33-93% with a mean of 66% (Table 3.3). Given that this was a 
heterogeneous group of isolates known to be unrelated, then mean Sd values for 
related isolates would be expected to be at least in the high 80’s or 90's. When 
the range of MSSA Sd values was looked at in detail, there appeared to be a 
greater number of matched pairs at the higher end of the curve (70-90%) than 
might be expected for an apparently heterogeneous group. This may be due to a 
combination of random matching, the way in which the gels were digitised and 
the computer software. Although all electrophoresis parameters were kept 
constant, the concentration of DNA prepared from each isolate tended to vary 
somewhat. Where the DNA concentration of an isolate was high, this had the 
effect of making the smaller fragments appear' closer together causing a smear 
effect which made digitising more difficult. Conversely, where DNA 
concentration was optimal, separation of the smaller fragments was clearer 
aiding the computer analysis. If two unrelated isolates were run on different 
gels and one had a high DNA concentration it was possible for them to appear 
to be more similar than they really were if they had some larger fragments in
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common but more vai’iation among smaller fragments which was not picked up 
on digitising.
The digitising of fragments in the 2 - 4 kb range was probably the main 
source of coincidental matching as human error in digitising becomes more 
significant as the fragments become less well resolved. Because of this 
difficulty in digitising smaller fragments and because veiy little fragment 
variation among MRSA was seen below 4kb, it is recommended in future 
analyses to set this value as the lower limit of the digitising window. The 
digitising system used was originally developed for use in building databases of 
plasmid REFP's, for which it has been highly successful as these fragments are 
generally well resolved following agarose gel electrophoresis (Rankin et ah, 
1995, Browning et al., 1995). However, the system does appear to have 
limitations when applied to genomic REFP's due to the difficulty encountered 
in resolving fragments less than approximately 4kb. Most workers now use 
fully automated gel documentation systems e.g. Gelcompar™ and Phoretix'^’^ , 
the latter of which has since superseded the digitising system in our 
department. Although simple to use, these systems are not yet optimal and lack 
suitable controls. Many users treat these systems as “black box” teclmology i.e. 
they have little or no understanding of the software algoritlims that produce the 
final results (dendrograms). Additionally, the manufacturers and marketers of 
such software may not have a sufficient understanding of molecular 
phylogenetic tree construction and the algorithms used to run the software may 
not be optimal. The human eye/brain system is very accurate at picking up any 
differences when examining REFP’s but a camera is more objective in such an
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examination. Computers are designed to equal the work of the brain/eye and 
effective QC is needed for manufacturers to set parameters to achieve this. 
Although the technology has advanced to such a level that a computer can 
equal the eye/brain system the algorithms required to run such systems often 
have not.
The Lisbon Strain
Phenotypically, the Lisbon strain was very stable. Only one and two 
isolates varied in their Tween 80 and urease reactions respectively. These 
results indicated that within specific clones of Staph, aureus, the urease 
reaction remained a relatively stable phenotypic trait that may be a useful strain 
marker when used in combination with other phenotypic characteristics. In 
addition, most isolates were urease positive which suggested that perhaps this 
enzyme is present in natural populations of Staph, aureus and that those 
isolates that were urease negative had either lost the gene for urease production, 
had a defective copy of the gene or expression of the gene was being 
suppressed by some mechanism.
Minor differences were seen in the antibiograms of nine isolates. The 
majority of these isolates (six) lacked the eiytlu’omycin / clindamycin resistance 
phenotype (MLS resistance). Loss of resistance to these agents is not 
uncommon in MRSA and may result from a loss or a lack of expression of 
Tn554.
Tn554 is ~6.7kb long and contains no restriction sites for Hhal 
(Genebank accession number U36912) therefore any copies of the transposon
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in these isolates would be present on fragments >6.7kb. Conversely if a Lisbon 
variant had deleted a copy of 7>z554, a deletion in a fragment >6.7kb would be 
visible on the Hhal REFP. The standard Lisbon Hhal REFP, which was found 
in 68 isolates was designated type LHl and all variants of this pattern were 
designated types LH2 -  LHl4. Two of the erythromycin sensitive isolates 
belonged to the Hhal type LHIO, characterised by the absence of an S.Okb 
fragment present in the LHl genotype (Table 3.1). A fragment of this size was 
present in all other Lisbon and French isolates with the exception of LHl 3. It 
is possible therefore that these two isolates had lost a copy of Tn554 from this 
fragment. Using a PCR protocol based on detection of Tn554 to characterise 
MRSA will be the focus of future work in order to add a further level of 
discrimination to the technique (Platt and Parsons, unpublished data).
The other four isolates of this group belonged to the LHl genotype, and 
since no observable DNA loss had occurred a possible explanation for the loss 
of MLS resistance in these isolates may be due to the loss of expression of the 
transposon or a mutation in the ermA gene.
One isolate (AB92) was susceptible to gentamicin and netilmicin while 
remaining resistant to streptomycin and kanamycin. Because resistance to 
aminoglycosides is the normal phenotype of this clone, it is reasonable to 
assume that this isolate had lost part of this trait. This isolate had a unique 
Hhal genomic REFP (LHl3), which corresponded to the loss of the S.Okb 
fragment and acquisition of an 8.1 and 6.2kb fragment. It is possible that the 
loss of this resistance trait correlated with changes in the genomic fmgeiprint.
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Gentamicin resistance in staphylococci is mediated by the transposon 
Tn4001 by way of the aminoglycoside modifying enzymes AAC(6') and APH 
(2"), however these enzymes also confer coincident resistance to tobramycin 
and kanamycin (Lyon et al., 1987). Transposon mutagenesis experiments have 
shown that the protein encoded by the gene aacA~aphT> possesses two 
domains, one of which produces the kanamycin and tobramycin phenotype, km*^  
tm%ia the AAC(6') activity and a second which mediates gentamicin resistance 
(gm"^ ) via the APH(2") activity. It is also known that sequences within the knT / 
tm‘ domain are essential for correct folding of the putative APH (2") active 
site. It may therefore be possible that a single mutation in one of these 
sequences may have allowed km  ^/ tm*^  to be expressed but resulted in abnormal 
folding of the APH (2") active site preventing expression of gm*^ .
Two isolates had acquired additional resistance determinants with no 
change in the standard (LHl) REFP type. One was resistant to fusidic acid the 
mechanism for which involves a cliromosomal mutation. Resistance to this 
agent tends to be sporadic and is generally as a result of recent exposure and 
selection. As with rifampicin, resistance is known to arise rapidly due to a 
spontaneous mutation when the agent is used alone. For this reason fusidic 
acid is generally used in combination with another antimicrobial agent.
The final antibiogram variant was due to the acquisition of 
trimethoprim resistance in an isolate belonging to the standard REFP type LHl 
(AB43). As has been previously stated, trimethoprim resistance (tp*^ ) is 
uncommon in MRSA isolates with the exception of certain defined clonal types 
e.g. EMRSA-1 and the Brazilian MRSA (De Sousa et al., 1998). It has been
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associated with a putative transposon Tn4003, a 4.7kb element that contains 3 
copies of the insertion sequence IS257. This element contains no restriction 
sites for Hhal therefore its presence would have been detected within the 
window set for Hhal genomic typing. The fact that no variation was seen in the 
genomic REFP therefore suggested that trimethoprim resistance in this isolate 
was not due to a Tn4003 insertion.
Although plasmid analysis was not performed on this isolate, a selection 
of Lisbon isolates were selected for plasmid profiling and REFP analysis. 
Preliminary results of this typing (data not shown) suggested that most isolates 
contained a single plasmid that had identical Hhal and Haelll REFP’s. Some 
isolates were plasmid free (this appeared to have no observable phenotypic 
effect). Future plasmid analysis of this isolate may help determine the nature of 
trimethoprim resistance in this isolate. As with Gram negative organisms, 
trimethoprim resistance in Staph, aureus can be either low level (10-500 mg/L) 
due to overproduction of chromosomal DHFR, or it may be high level 
(>1000mg/L) which is typically plasmid mediated. A simpler method of 
determining the nature of this resistance may therefore be to perform a 
trimethoprim MIC on the isolate.
The window given by Hhal enabled -  120 -  130kb of DNA to be 
visualised as discrete fragments that ranged from 3.7 -  15kb. Clearly as the 
staphylococcal genome measures -2.7Mb (Pattee et al., 1990), we are looking 
at a small percentage (~5%) of the total cellular DNA. This type of approach in 
a typing technique has two potential problems. Firstly, if the genome contains 
a large number of hyper-variable regions then the technique will be too
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sensitive, showing variation perhaps in every isolate examined and therefore 
data saturation occurs very quickly. Conversely, if the technique targets areas 
of the genome which are highly conserved then little or no variation will be 
seen therefore the technique lacks the necessary discrimination needed to be a 
useful typing tool.
The selected control groups were able to show that the teclmique does 
not suffer from either of these pitfalls. By continuous subculture of a 
representative Lisbon isolate at different temperatures, we were also able to 
show that the genotype of the strain remained stable over a six month period 
and that no observable change in phenotype occurred.
Genomic variation seen in the Lisbon strain
When the Lisbon strain first appeared in Scotland it was easily 
recognised as a new strain of MRSA when isolated from clinical specimens due 
to its unusual resistance phenotype (in addition to the fact that it was isolated 
from a patient that had just anived in the country from Portugal). Prior to this, 
multi-resistant strains were encountered only infrequently and this strain was 
even more unusual in being resistant to all aminoglycosides and to rifampicin 
which proved a good strain marker. Shortly following the recognition of this 
new MRSA a second multi-resistant strain was recognised. This strain 
although very similar to the Lisbon strain was epidemiologically unrelated and 
differed in its degree of resistance to rifampicin. Because of this it was 
uncertain whether or not this was a different strain or simply a phenotypic 
variant of the Lisbon strain and since the strain was thought to have been
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imported from France it became known locally as the “French strain” MRSA. 
MRSA with this phenotype were isolated only very occasionally and were soon 
replaced by the more persistent Lisbon strain.
One of the aims of the thesis was to address this question of the 
relationship between the two MRSA phenotypes. As Figures 3.17 and 3.18 
clearly showed, Hhal REFP’s confirmed that both “types” belonged to the same 
clonal lineage and the mean Dice coefficient for matching the two groups was 
94% (Table 3.4). It was also apparent from the analysis that the French variant 
FrH5 was identical in REFP to Lisbon variant LH4 i.e. they were both lacking a 
5.3kb fragment present in Lisbon variant HI (Figure 3.17).
It should be noted that in order to construct the flow diagram outlining 
the possible evolutionary sequence of the Lisbon strain we have made the 
important assumption that all variants have descended from the type LHL This 
assumption was based on:
1. the index case typing as this REFP
2. 73% of the isolates gave this REFP
3. of the two oldest isolates in the collection, one had the LHl REFP.
It is recognised that this assumption may be flawed but given the data 
obtained it is probably a reasonable proposal of events. It may be equally 
correct to assume that variant LH3 was the original genotype since the first 
isolation of this type was at the same time (01/12/90). It is possible that this 
sub-type diverged into a further five sub-types with the loss or gain of a single 
fragment (assumed to be a single genetic event) whereas LHl gives rise to only
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four. However, as LHl was the most frequently isolated genotype (from many 
sites in WOS), this suggested that it was genetically the most stable or “fittest” 
sub-type. One other possibility for the appearance of variants is the secondary 
importation of another variant of the Iberian clone MRSA. Given that the 
French variant of the Lisbon strain was a secondary import, this explanation is 
quite plausible particularly for those variants that cannot be arrived at by a 
single step.
In late 1989, a Spanish Reference Laboratory noted an increase in 
numbers of MRSA belonging to phage type 29/77/84/932. These isolates were 
found in several hospitals in different cities suggesting spread of an epidemic 
strain. Aparicio and co-workers (1992) characterised these isolates by 
phenotypic and genotypic methods. Included in these study isolates were two 
isolates representative of outbreaks that had occurred in the UK due to the 
return of an infected patient from Spain in 1990. They used conventional 
electrophoresis of whole cell DNA with several enzymes but failed to 
discriminate conclusively between isolates. However, phenotyping of these 
isolates suggested two variants based on phage typing. Most importantly, the 
phenotyping suggested that this strain was part of the Iberian Clone and 
therefore related to the Lisbon strain, which appeared in Scotland also around 
the same time. This has implications for the evolution of the Lisbon strain in 
Scotland. It may help explain the existence of variants that cannot be arrived at 
by a single genetic event fr’om another subtype (Figure 3.18) by implying that 
such isolates may have arrived in Scotland from other sources not connected to 
the index case.
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As the strain spread to new locations or new patients, it would be 
subjected to a number of different selection pressmes and in so doing may have 
undergone mutation in the form of deletions, insertions and rearrangements of 
its genomic DNA. Where these changes occurred within a Hhal restriction site 
they would be detected on REFP typing if the fragments were large enough. 
Also, if a DNA insertion is large enough it can be detected on the REFP 
without necessarily being within a restriction site. These types of genetic 
events can lead to the development of numerous genetic variants of the type 
strain. The majority of these variants would be unstable, some mutations may 
eventually be lethal and the variants would therefore be unable to establish 
themselves. This seems to be the most likely explanation for the existence of 
the Lisbon sub-types since, with the exception of LH2, LFI3 and to a lesser 
extent LHIO, all other variants were encountered once only. In the case of LH2 
these isolates span a period of 5 years from 1991 -  96. It is possible that LHl 
diverged to give a stable variant that had survived at a low level being detected 
only infrequently over the years.
The results obtained in this study have shown that the Lisbon strain is 
very closely related genetically to the Iberian clone first described in Spain by 
Dominguez and co-workers (1994). Since its discovery, molecular surveillance 
studies have identified the clone in Spain, Portugal, Belgium, Germany, Italy, 
Scotland and USA (Mato et al., 1998)
As part of the above collaborative study (Mato) to investigate the 
geographical spread of the "Iberian" clone of MRSA, a selection of MRSA 
comprising 7 Lisbon variants, 2 French variants and 4 sporadic MRSA were
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sent to Portugal for further epidemiological typing. This included Smal PFGE, 
Clal-mecA typing and Cla\-Tn554 typing. Using these methods previously, 
Sanches et al. (1995) designated the typical Iberian clone the type I:;E::A; 
where I is the mec A  type, E is the Tn554 type and A is the pulse field type. Of 
the Lisbon isolates, 3 conformed to this typical type (LHl, LH5 and LH6). All 
had unique PFGE types which were sub-types of A (as with the Hhal type) and 
all had the mecA polymorph I. Four Lisbon isolates had unique Tn554 types. 
One French variant differed from Lisbon in both mecA polymorph (VI) and 
Tn554 type although it was closely related by PFGE. Most importantly, the 
results of PFGE / mec A  / Tn554 typing confirmed the results of Hhal genomic 
REFP's in demonstrating that the Lisbon and French strain MRSA are part of 
the Iberian MRSA clone. In addition, the Tn554 types appear to have become 
more diverse among Scottish isolates of the Iberian clone when compared to 
those from Italy, Spain and Portugal. As yet reasons for this are unclear but 
this apparent increased Tn554 diversity may be the focus of future work. One 
possible mechanism may be different selection pressures exerted by different 
approaches to antimicrobial usage in the respective countries.
Conclusions
This study has shown that Hhal and to a lesser extent SauSAl are 
valuable tools for epidemiological typing and the successful application of the 
technique resulted in all of the Study aims being achieved. Epidemiologically 
unrelated MRSA were shown to be genotypically diverse but to a lesser extent 
than MSSA; all isolates phenotypically designated as Lisbon strain MRSA
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were closely genotypically related consistent with the expansion o f a single 
clone; Hhal was sufficiently discriminating to allow the recognition of several 
molecular variants of this clonal group; and by application of Dice coefficients, 
no control group was shown to be closely related either to each other or to the 
Lisbon group.
Future work 
Investigation o f  anomalies
The study has highlighted several interesting features of MRSA genetics 
which necessitate further investigation. Firstly, the anomalies in some of the 
study results will be addressed for completeness e.g. the conflicting Hhal / 
SauSAl / phenotype results of the EMRSA-15 variants ABIOO and ABU4; the 
additional aminoglycoside resistance in some of the EMRSA-16 isolates; 
mechanisms involved in loss of aminoglycoside resistance and gain of 
trimethoprim resistance (AB92 and AB43, respectively) and further 
investigation of the “French strain” MRSA which yielded an unrelated PFGE 
type from the collaborative work of Mato et n/.(1995). A closer investigation 
of Tn554 in the Lisbon strain may prove interesting as the preliminary 
investigations of Mato et al. suggested that the Tn554 types were more diverse 
among Scottish isolates. Further investigation of the “Stobhill clone” MRSA is 
also warranted to determine if it is still present in the hospital since the 
appearance of EMRSA-15 and EMRSA-16.
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PFGE comparative study
A comparative study of Hhal / SauSAl genotyping and PFGE typing 
must be a priority as this will yield more valuable information not only on the 
relative discriminatory powers of the two techniques but also their respective 
capacity to detect more distant relationships between strains. The time factor 
involved in obtaining Hhal I SauSAl typing results is a considerable drawback 
to the technique and should also be addressed with the aim of achieving an 
extraction protocol which provides a result within 24 hours from an overnight 
broth culture as this is now possible with PFGE (SMRL, unpublished data).
MRSA plasmids
Although outwith the main scope of this thesis, the plasmid data should 
be investigated in more detail and characterisation of the Lisbon strain 
plasmid(s) and relationships to other MRSA would also yield valuable data. 
The preliminary results of plasmid typing suggested that most isolates of 
Lisbon MRSA possessed a single plasmid which showed no variation on REFP 
when digested with Hhal or Haelll and this plasmid appeared to be unrelated to 
plasmids found in EMRSA-15 and EMRSA-16.
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Preparation of Media and Reagents
1. Brain Heart Infusion Broth (Oxoid CM225)
36g of BHÎ powder were dissolved in one litre of distilled water, 
distributed in 10ml amounts in glass universals and sterilised by 
autoclaving at 121°C for 15 minutes.
2. Todd Hewitt Broth (Oxoid CM225)
36.4g of THB powder were dissolved in one litre of distilled water, 
distributed in 10ml amounts in glass universals and sterilised by 
autoclaving at 115°C for 15 minutes.
3. TES Buffer
Tris base (Sigma) 50mM 3.03g
Sodium chloride (Analai') 50mM 1.46g
Di-sodium EDTA (Sigma) 5mM 0.93g
Made up as required by dissolving in 400ml of distilled water and
adjusting pH to 8.0 with conc. HCI. The remainder of distilled water was 
added to give a final volume of 500ml. Stored at 4°C.
4. TESS Buffer
Prepared as above with the inclusion of 50mM sucrose (Sigma).
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5. Lysostaphin (Sigma)
Used at a conc. of lOOOunits/ml. Reconstituted to this concentration with 
distilled water and distributed in 1ml amounts in sterile Eppendorf tubes. 
Stored at -70°C.
6. Lysozyme (Sigma)
Prepared freshly each time. Used at a concentration of 40pg/ml. 
Reconstituted to this concentration with distilled water by adding 0.12g 
to 3ml of distilled water. This gave enough to lyse 8 isolates.
7. 20 % Sodium dodecyl sulphate (Sigma)
Prepared by dissolving 2g of SDS in 10ml of sterile distilled water. 
Stored at room temperature.
8. Proteinase K (Sigma)
Reconstituted to lOmg/ml in sterile distilled water. Distributed in 1.3ml 
amounts in sterile Eppendorf tubes. Each tube contained enough 
proteinase K for 8 isolates. Stored at -20°C.
9. Isopropanol (Sigma)
A working volume only (<50ml) was kept on the bench at any time. The 
stock bottle was stored in the “flammable” cupboard.
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10. Phenol / Chloroform (Analar)
25 Og of detached phenol crystals was added to 250ml of chlorofomi in 
the fume cupboard in a 2 litre flask. This was allowed to stand until 
completely dissolved. 50ml of TGE was added and mixed well. The 
mixture was transferred to a dark bottle and the aqueous layers allowed to 
separate before use. Stored at 4°C.
11. TGE Buffer
Tris (Sigma) 25mM 1.5g
Di-sodium EDTA (Sigma) lOmM 1.85g
Glucose (Analar) 50mM 4.5g
Dissolved in 100ml distilled water, pH adjusted to 8.0 with HCI and 
made up to 500ml with distilled water. Sterilised by autoclaving at 
110°C for 10 minutes. Stored at room temperature.
12. TE Buffer
Tris base (Sigma) lOmM 0.605g
Disodium EDTA (Sigma) ImM 0.186g
Dissolved in 400ml of distilled water and pH adjusted to 8.0 with HCI. 
Final volume made up to 500ml with distilled water and autoclaved at 
121°C for 15 minutes.
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13. TEio Buffer
Tris base (Sigma) lOmM 0.605g
Disodium EDTA (Sigma) lOmM 1.86g
Dissolved in 400ml of distilled water and pH adjusted to 7.8 with HCl.
Final volume made up to 500ml with distilled water and autoclaved at
121 °C for 15 minutes.
14. 7.5 M Ammonium acetate (Sigma)
57.3g was dissolved in 50ml of distilled water and pH adjusted to 8.0 
with glacial acetic acid. Made up to 100ml with distilled water. Stored 
at room temperature. This was replaced regularly (monthly) as it was 
unstable.
15. Absolute Ethanol (BDH)
As with isopropanol, only a working volume was kept on bench and the 
stock bottle stored in “flammable” cupboard.
16. RNase (Sigma)
Prepared at a working concentration of lOmg/ml by dissolving lOOmg in 
10ml of distilled water. This was then split into three aliquots in glass 
universals, placed in a beaker of water and boiled for 10 minutes. Stored 
at 4°C.
163
17. Tris - borate Buffer (TBE)
Tris base (Sigma) 89mM 53.9g
Boric acid (Sigma) 89mM 27.5g
Di-sodium EDTA (Sigma) 1.25mM 2.3g
Diy chemicals were weighed out for 5L batches of buffer and stored in 
plastic jars at room temperature until required, then the jar contents were 
added of to 5L of distilled water. The pH was adjusted to within the 
range 8.0 - 8.4.
18. Agarose (Sigma)
A 0.6% gel was prepared by dissolving 3g in 500ml of TBE buffer. This 
was boiled until completely dissolved and cooled to just below 50°C 
before pouring.
19. Ethidium Bromide (Sigma)
A stock solution of lOmg/ml was made. Gels were stained in used 
electrophoresis buffer (TBE) containing a final conc. of 0.5 -1.0 jiig/ml of 
ethidium bromide.
N.B. this chemical is a powerful mutagen and gloves were worn 
at all times when handling.
t
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20. Tracking dye
Sucrose (Sigma) 25g
Sodium acetate (Sigma) 60mg
SDS (Sigma) lOOmg
Bromophenol blue (Sigma) 50mg
Dissolved in distilled water and made up to 100ml. Stored at room 
temperature.
21. 20 % Sodium sulphite (Analar)
Dissolved 200g in 1 litre of distilled water. Stored at room temperature 
in a dark bottle.
  --------------------------------
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computer generated 
matching pair data
1 6 6
A ppendix II (a) Com puter generated print out o f  DN A fragm ent sizes o f
Lisbon and French M R SA  m olecular variants
20 Sizes
7.99 2
4.48 2
3.69 3
19 Sizes
7.99 2
4.34 3
21 Sizes
7.99 2
4.63 2
3.83 2
19 Sizes
7.99 2
4.34 3
18 Sizes 
7.99 2
4.18 2
20 Sizes
6.85 2
4.48 2
3.69 3
22 Sizes 
10.08 2
4.73 2
3.88 2
23 Sizes
7.99 2
4.88 2
3.95 2
20 Sizes
7.99 2
4.48 2
3.69 3
19 Sizes
6.85 2
4.34 3
Track 0 LIS HI Hhal
15.03 2 12.57 2 11.70 2
4.88 2 4.73 2 4.63 3
3.95 2 3.88 2 3.83 2
Track 1 LIS H2 Hhal
15.03 2 12.57 2 11.70 2
4.73 2 4.63 3 4.48 2
3.88 2 3.83 2 3.69 3
Track 2 LIS H3 Hhal
15.03 2 12.57 2 11.70 2
5.09 3 4.88 2 4.73 2
4.02 2 3.95 2 3.88 2
Track 3 LIS H4 Hhal
15.03 2 12.57 2 11.70 2
4.73 2 4.63 3 4.48 2
3.88 2 3.83 2 3.69 3
Track 4 LIS H5 Hhal
15.03 2 12.57 2 11.70 2
4.63 3 4.48 2 4.34 3
3.83 2 3.69 3
Track 5 LIS H6 Hhal
15.03 2 11.70 2 7.99 2
4.88 2 4.73 2 4.63 3
3.95 2 3.88 2 3.83 2
Track 6 LIS H7 Hhal
15.03 2 12.57 2 11.70 2
5.32 2 5.09 3 4.88 2
4.11 2 4.02 2 3.95 2
Track 7 LIS H8 Hhal
15.03 2 12.57 2 11.70 2
5.77 2 5.32 2 5.09 3
4.18 2 4.11 2 4.02 2
Track 8 LIS H9 Hhal
15.03 2 12.57 2 11.70 2
4.88 2 4.73 2 4.63 3
3.95 2 3.88 2 3.83 3
Track 9 LIS HIO Hhal
15.03 2 12.57 2 11.70 2
4.73 2 4.63 3 4.48 2
3.88 2 3.83 2 3.69 3
6.85 2 5.77 2 5.32 2 5.09
4.34 3 4.18 2 4.11 2 4.02
6.85 2 5.32 2 5.09 3 4.88
4.18 2 4.11 2 4.02 2 3.95
6.85 2 6.40 2 5.77 2 5.32
4.48 2 4.34 3 4.18 2 4.11
3.69 3
6.85 2 5.77 2 5.09 3 4.88
4.18 2 4.11 2 4.02 2 3.95
6.85 2 5.09 2 4.88 2 4.73
4.11 2 4.02 2 3.95 2 3.88
6.40 2 5.77 2 5.32 2 5.09
4.34 3 4.18 2 4.11 2 4.02
7.99 2 6.85 2 6.40 2 5.77
4,63 3 4.48 2 4.34 3 4.18
3.83 2 3.69 3
7.70 2 6.85 2 6.61 2 6.40
4.73 2 4.63 2 4.48 2 4.34
3.88 2 3.83 2 3.69 3
6.85 2 5.77 2 5.52 2 5.09
4.34 3 4.18 2 4.11 2 4.02
5.77 2 5.32 2 5.09 3 4.88
4.18 2 4.11 2 4.02 2 3.95
L IS  = Lisbon variants 
F r. = French variants
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Appendix II (a) Contd.
Track 10 LIS H ll Hhal 24 Sizes
15.03 2 12.57 2 11.70 2 8.30 2 7.99 2 7.39 2 6.85 2 6.40
6.20 2 5.77 2 5.32 2 5.09 3 4.88 2 4.73 2 4.63 3 4.48
4.34 3 4.18 2 4.11 2 4.02 2 3.95 2 3.88 2 3.83 2 3.69
Track 11 LIS H12 Hhal 22 Sizes
15.03 2 12.57 2 11.70 2 7.99 2 6.85 2 6.40 2 6.20 2 5.77
5.32 2 5.09 3 4.88 2 4.73 2 4.63 3 4.48 2 4.34 3 4.18
4.11 2 4.02 2 3.95 2 3.88 2 3.83 2 3.69 3
Track 12 LIS HI3 Hhal 21 Sizes
15.03 2 12.57 2 11.70 2 8.15 2 6.85 2 6.20 2 5.77 2 5.32
5.09 3 4.88 2 4.73 2 4.63 3 4.48 2 4.34 3 4.18 2 4.11
4.02 2 3.95 2 3.88 2 3.83 2 3.69 3
Track 13 LIS H14 Hhal 22 Sizes
15.03 2 12.57 2 11.70 2 8.30 2 7.99 2 6.85 2 6.40 2 5.77
5.32 2 5.09 3 4.88 2 4.73 2 4.63 3 4.48 2 4.34 2 4.18
4.11 2 4.02 2 3.95 2 3.88 2 3.83 2 3.69 3
Track 14 Fr HI Hhal 21 Sizes
15.03 2 12.57 2 11.70 2 8.97 2 7.99 2 6.85 2 6.23 2 5.77
5.09 3 4.88 2 4.73 2 4.63 3 4.48 2 4.34 3 4.18 2 4.11
4.02 2 3.95 2 3.88 2 3.83 2 3.69 3
Track 15 Fr H2 Hhal 23 Sizes
15.03 2 12.57 2 11.70 2 8.97 2 7.99 2 6.85 2 6.23 2 5.97
5.77 2 5.33 2 5.09 3 4.88 2 4.73 2 4.63 3 4.48 2 4.34
4.18 2 4.11 2 4.02 2 3.95 2 3.88 2 3.83 2 3.69 3
Track 16 Fr H3 Hhal 20 Sizes
15.03 2 12.57 2 11.70 2 8.97 2 7.99 2 6.85 2 5.77 2 5.09
4.88 2 4.73 2 4.63 3 4.48 2 4.34 3 4.18 2 4.11 2 4.02
3.95 2 3.88 2 3.83 2 3.69 3
Track 17 Fr H4 Hhal 20 Sizes
15.03 2 12.57 2 11.70 2 7.99 2 6.85 2 6.23 2 5.77 2 5.09
4.88 2 4.73 2 4.63 3 4.48 2 4.34 3 4.18 2 4.11 2 4.02
3.95 2 3.88 2 3.83 2 3.69 3
Track 18 Fr H5 Hhal 19 Sizes
15.03 2 12.57 2 11.70 2 7.99 2 6.85 2 5.77 2 5.09 3 4.88
4.73 2 4.63 3 4.48 2 4.34 3 4.18 2 4.11 2 4.02 2 3.95
3.88 2 3.83 2 3.69 3
NB. "Number 2 or 3 beside fragment size indicates whether fragment was estimated as a doublet or triplet.
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Appendix II (b) C om puter generated print out o f Dice coefficients from  m atches
between Lisbon and French M RSA m olecular variants
Fragment sizes between 3.69kb and 15.03kb 
Fragment size variation <=5.0%
Similarity coeff. >1.0%
Sim.
Coeff (M) Tk. Pts Organism Enzyme Tk. Pts Organism Enzyme
97.4 (19) 0 20/20 LIS HI Hhal 1 19/19 LIS H2 Hhal
97.6 (20) 0 20/20 LIS HI Hhal 2 21/21 LIS H3 Hhal
97.4(19) 0 20/20 LIS HI Hhal 3 19/19 L1SH4 Hhal
94.7(18) 0 20/20 LIS HI Hhal 4 18/18 LIS H5 Hhal
95.0(19) 0 20/20 LIS HI Hhal 5 20/20 LIS H6 Hhal
95.2 (20) 0 20/20 LIS HI Hhal 6 22/22 LIS H7 Hhal
93.0 (20) 0 20/20 LIS HI Hlial 7 23/23 LIS H8 Hhal
100.0 (20) 0 20/20 LIS HI Hhal 8 20/20 LIS H9 Hhal
97.4(19) 0 20/20 LIS HI Hhal 9 19/19 LIS HIO Hhal
90.9 (20) 0 20/20 LIS HI Hhal 10 24/24 LIS H ll Hhal
95.2 (20) 0 20/20 LIS HI Hhal 11 22/22 L1SH12 Hhal
97.6 (20) 0 20/20 LIS HI Hhal 12 21/21 LIS H 13 Hhal
95.2 (20) 0 20/20 LIS HI Hhal 13 22/22 LIS H14 Hhal
92.7 (19) 0 20/20 LIS HI Hhal 14 21/21 FrHl Hhal
93.0(20) 0 20/20 LIS HI Hhal 15 23/23 FrH2 Hhal
95 .0 (1 9 ) 0 20/20 LIS HI Hhal 16 20/20 FrH3 Hhal
95.0(19) 0 20/20 LIS HI Hhal 17 20/20 FrH4 Hhal
97.4 (19) 0 20/20 LIS HI Hhal 18 19/19 Fr H5 Hhal
95.0(19) 1 19/19 LIS H2 Hhal 2 21/21 LIS H3 Hhal
94.7(18) 1 19/19 LÏSH2 Hhal 3 19/19 LIS H4 Hhal
97.3 (18) 1 19/19 LIS H2 Filial 4 18/18 LIS H5 Flhal
92.3 (18) 1 19/19 LIS H2 Hhal 5 20/20 LISH6 Hhal
92.7(19) 1 19/19 LIS H2 Hhal 6 22/22 LISH7 Hhal
90.5 (19) 1 19/19 LIS H2 Hhal 7 23/23 LISH8 Hhal
97.4(19) 1 19/19 LISH2 Hhal 8 20/20 LIS H9 Hhal
94.7(18) 1 19/19 LISH2 Hhal 9 19/19 LIS HIO Hhal
88.4(19) 1 19/19 LISH2 Hhal 10 24/24 LIS H ll Hhal
92.7 (19) 1 19/19 LISH2 Hhal 11 22/22 LISH12 Hhal
95.0(19) 1 19/19 LIS H2 Hhal 12 21/21 LISH13 Hhal
92.7 (19) 1 19/19 LIS H2 Hhal 13 22/22 LISH14 Hhal
90.0(18) 1 19/19 LISH2 Hhal 14 21/21 FrHl Hhal
90.5(19) 1 19/19 LIS H2 Hhal 15 23/23 FrH2 Hhal
92.3 (18) 1 19/19 LIS H2 Hhal 16 20/20 FrH3 Hhal
92.3(18) 1 19/19 LIS H2 Hhal 17 20/20 FrH4 Hhal
94.7(18) 1 19/19 LIS H2 Hhal 18 19/19 FrH5 Hhal
(M) = Matching fragments number
Tk, = Gel track number
Pts. = Number o f fr agments compared
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Sim.
:oeff (M) Tk. Pts Organism Enzyme Tk. Pts Organism Enzyme
95.0(19) 1 21/21 LIS H3 Hhal 3 19/19 LIS H4 Hhal
92.3(18) 1 21/21 LISH3 Hhal 4 18/18 LIS H5 Hhal
97.6 (20) 1 21/21 LIS H3 Hhal 5 20/20 LIS H6 Hhal
97.7 (21) 1 21/21 LIS H3 Hlial 6 22/22 LIS H7 Hhal
95.5 (21) 1 21/21 LISH3 Hhal 7 23/23 LISH8 Hhal
97.6 (20) 2 21/21 LIS H3 Hhal 8 20/20 LIS H9 Hhal
95.0(19) 2 21/21 LISH3 Hhal 9 19/19 LIS HIO Hhal
93.3 (21) 2 21/21 LIS H3 Hhal 10 24/24 LIS H ll Hhal
97.7 (21) 2 21/21 LIS H3 Hhal 11 22/22 LISH12 Hhal
100.0 (21) 2 21/21 LIS H3 Hhal 12 21/21 LISH13 Hhal
97.7(21) 2 21/21 LIS H3 Hhal 13 22/22 LISH14 Hhal
95.2 (20) 2 21/21 LISH3 Hhal 14 21/21 FrHl Hhal
95.5(21) 2 21/21 LISH3 Hhal 15 23/23 Fr H2 Hhal
92.7(19) 2 21/21 LISH3 Hhal 16 20/20 Fr H3 Hhal
97.6 (20) 2 21/21 LISH3 Hhal 17 20/20 FrH4 Hhal
95.0 (19) 2 21/21 LIS H3 Hhal 18 19/19 FrH5 Hhal
97.3 (18) 3 19/19 LISH4 Hhal 4 18/18 LIS H5 Hhal
92.3(18) 3 19/19 LISH4 Hhal 5 20/20 LIS H6 Hhal
92.7 (19) 3 19/19 LIS H4 Hhal 6 22/22 LIS H7 Hhal
90.5(19) 3 19/19 LISH4 Hhal 7 23/23 LIS H8 Hhal
97.4(19) 3 19/19 LISH4 Hhal 8 20/20 LIS H9 Hhal
94.7(18) 3 19/19 LISH4 Hhal 9 19/19 LIS HIO Hhal
88.4(19) 3 19/19 LIS H4 Hhal 10 24/24 LIS H ll Hhal
92.7(19) 3 19/19 LISH4 Hhal 11 22/22 LISH12 Hhal
95.0 (19) 3 19/19 LISH4 Hhal 12 21/21 LIS HI3 Hhal
92.7 (19) 3 19/19 LIS H4 Hhal 13 22/22 LIS H14 Hhal
95.0(19) 3 19/19 LIS H4 Hhal 14 21/21 FrHl Hhal
90.5 (19) 3 19/19 LIS H4 Hhal 15 23/23 FrH2 Hhal
97.4 (19) 3 19/19 LISH4 Hhal 16 20/20 FrH3 Hhal
97.4(19) 3 19/19 LIS H4 Hhal 17 20/20 FrH4 Hhal
100.0(19) 3 19/19 LISH4 Hhal 18 19/19 FrH5 Hhal
89.5 (17) 4 18/18 LIS H5 Hhal 5 20/20 LIS H6 Hhal
90.0(18) 4 18/18 LIS H5 Hhal 6 22/22 LIS H7 Hhal
87.8(18) 4 18/18 LIS H5 Hhal 7 23/23 LIS H8 Hhal
94.7 (18) 4 18/18 LIS H5 Hhal 8 20/20 LIS H9 Hhal
91.9(17) 4 18/18 LIS H5 Hhal 9 19/19 LIS HIO Hhal
85.7(18) 4 18/18 LIS H5 Hhal 10 24/24 LIS H ll Hhal
90.0(18) 4 18/18 LIS H5 Hhal 11 22/22 LISHÎ2 Hhal
92.3 (18) 4 18/18 LIS H5 Hhal 12 21/21 LIS H13 Hhal
90.0(18) 4 18/18 LIS H5 Hhal 13 22/22 LISHI4 Hhal
92.3 (18) 4 18/18 LIS H5 Hhal 14 21/21 FrHl Hhal
87.8(18) 4 18/18 LIS H5 Hhal 15 23/23 Fr H2 Hhal
94.7(18) 4 18/18 LIS H5 Hhal 16 20/20 FrH3 Hhal
94.7(18) 4 18/18 LISH5 Hhal 17 20/20 Fr H4 Hhal
97.3 (18) 4 18/18 L1SH5 Hhal 18 19/19 FrH5 Hhal
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Sim.
Coeff (M) Tk. Pts Organism Enzyme Tk. Pts Organism Enzyme
95.2 (20) 5 20/20 LIS H6 Hhal 6 22/22 LISH7 Hhal
93.0 (20) 5 20/20 L1SH6 Hhal 7 23/23 LISH8 Hhal
95.0(19) 5 20/20 LIS H6 Hhal 8 20/20 LIS H9 Hhal
92.3(18) 5 20/20 LIS H6 Hhal 9 19/29 LIS HIO Hhal
90.9 (20) 5 20/20 LÏSH6 Hhal 10 24/24 LIS H ll Hhal
95.2 (20) 5 20/20 LIS H6 Hhal 11 22/22 LISH12 Hhal
97.6 (20) 5 20/20 LIS H6 Hhal 12 21/21 LIS HI3 Hhal
95.2 (20) 5 20/20 LIS H6 Hhal 13 22/22 LIS H 14 Hhal
92.7 (20) 5 20/20 LIS H6 Hhal 14 21/21 FrHl Hhal
93.0 (20) 5 20/20 LISH6 Hhal 15 23/23 FrH2 Hhal
90.0(18) 5 20/20 LIS H6 Hhal 16 20/20 FrH3 Hhal
95.0(19) 5 20/20 LIS H6 Hhal 17 20/20 FrH4 Hhal
92.3 (18) 5 20/20 LIS H6 Hhal 18 19/19 FrH5 Hhal
93.3 (21) 6 22/22 LIS H7 Hhal 7 23/23 LIS H8 Hhal
95.2 (20) 6 22/22 LIS H7 Hhal 8 20/20 LIS H9 Hhal
92.7(19) 6 22/22 L1SH7 Hhal 9 19/19 LIS HIO Hhal
91.3 (21) 6 22/22 LIS H7 Hhal 10 24/24 LIS HI I Hhal
95.5 (21) 6 22/22 LIS H7 Hhal 11 22/22 LISH12 Hhal
97.7 (21) 6 22/22 LIS H7 Hhal 12 21/21 LISH13 Hhal
95.5 (21) 6 22/22 LIS H7 Hhal 13 22/22 LIS H14 Hhal
93.0(20) 6 22/22 LIS H7 Hhal 14 21/21 FrHl Hhal
93.3 (21) 6 22/22 LIS H7 Hhal 15 23/23 FrH2 Hhal
90.5(19) 6 22/22 LIS H7 Hhal 16 20/20 Fr H3 Hhal
95.2 (20) 6 22/22 LIS H7 Hhal 17 20/20 FrH4 Hhal
92.7 (19) 6 22/22 LIS H7 Elhal 18 19/19 FrH5 Hhal
93.0 (20) 7 23/23 LIS H8 Hhal 8 20/20 LIS H9 Hhal
90.5 (19) 7 23/23 LIS H8 Hhal 9 19/19 LIS HIO Hhal
97.9 (23) 7 23/23 LIS H8 Hhal 10 24/24 LIS H ll Hhal
97.8 (22) 7 23/23 LIS H8 Hhal 11 22/22 LIS H12 Hhal
95.5 (21) 7 23/23 LIS H8 Hhal 12 21/21 LISH13 Hhal
97.8 (22) 7 23/23 LIS H8 Hhal 13 22/22 LISH14 Hhal
90.9 (20) 7 23/23 LIS H8 Hhal 14 21/21 FrHl Hhal
91.3 (21) 7 23/23 LIS H8 Hhal 15 23/23 FrH2 Hhal
88.4(19) 7 23/23 LIS H8 Hhal 16 20/20 FrH3 Hhal
93.0 (20) 7 23/23 LIS H8 Hhal 17 20/20 FrH4 Hhal
90.5(19) 7 23/23 LIS H8 Hhal 18 19/19 FrH5 Hhal
97.4 (19) 8 20/20 LIS H9 Hhal 9 19/19 LIS HIO Hhal
90.9 (20) 8 20/20 LIS H9 Hhal 10 24/24 LIS HI 1 Hhal
95.2 (20) 8 20/20 LIS H9 Hhal 11 22/22 LIS H12 Hhal
97.6 (20) 8 20/20 LIS H9 Hhal 12 21/21 LIS H13 Hhal
171
Sim.
Coeff (M) Tk. Pts Organism Enzyme Tk. Pts Organism Enzyme
95.2 20) 8 20/20 LIS H9 Hhal 13 22/22 LISH14 Hhal
92.7 19) 8 20/20 LIS H9 Hhal 14 21/21 FrHl Hhal
93.0 20) 8 20/20 LIS H9 Hhal 15 23/23 FrH2 Hhal
95.0 19) 8 20/20 LIS H9 Hhal 16 20/20 FrH3 Hhal
95.0 19) 8 20/20 LIS H9 Hhal 17 20/20 FrH4 Hhal
97.4 19) 8 20/20 LIS H9 Hhal 18 19/19 FrH5 Hhal
88.4 19) 9 19/19 LIS HIO Hhal 10 24/24 LIS HI I Hhal
92.7 19) 9 19/19 LIS HIO Hhal 11 22/22 LIS H12 Hhal
95.0 19) 9 19/19 LIS HIO Hhal 12 21/21 L1SH13 Hhal
92.7 19) 9 19/19 LIS HIO Hhal 13 22/22 LISH14 Hhal
90.0 18) 9 19/19 LIS HIO Hhal 14 21/21 FrHl Hhal
90.5 19) 9 19/19 LIS HIO Hhal 15 23/23 Fr H2 Hhal
92.3 18) 9 19/19 LIS HIO Hhal 16 20/20 FrH3 Hhal
92.3 18) 9 19/19 LIS HIO Hhal 17 20/20 Fr H4 Hhal
94.7 18) 9 19/19 LIS HIO Hhal 18 19/19 FrH5 Hhal
95.7 22) 10 24/24 LIS H ll Hhal 11 22/22 L1SH12 Hhal
93.3 21) 10 24/24 LIS HI 1 Hhal 12 21/21 LIS HI3 Hhal
95.7 22) 10 24/24 LIS HI I Hhal 13 22/22 LIS H 14 Hhal
88.9 20) 10 24/24 LIS H ll Hhal 14 21/21 FrHl Hhal
93.6 22) 10 24/24 LIS H ll Hhal 15 23/23 FrH2 Hhal
86.4 19) 10 24/24 LIS H ll Hhal 16 20/20 FR H3 Hhal
90.9 20) 10 24/24 LIS H ll Hhal 17 20/20 FrH4 Hhal
88.4 19) 10 24/24 LIS HI I Hhal 18 19/19 FrH5 Hhal
97.7 21) 11 22/22 LISH12 Hhal 12 21/21 LISH13 Hhal
95.5 21) 11 22/22 LISH12 Hhal 13 22/22 LISH14 Hhal
93.0 20) 11 22/22 LIS H12 Hhal 14 21/21 FrHl Hhal
97.8 22) 11 22/22 LISHI2 Hhal 15 23/23 FrH2 Hhal
90.5 19) 11 22/22 LISH12 Hhal 16 20/20 FrH3 Hhal
95.2 20) 11 22/22 LIS H12 Hhal 17 20/20 FrH4 Hhal
92.7 19) 11 22/22 LIS H12 Hhal 18 19/19 FrH5 Hhal
97.7 21) 12 21/21 LISH13 Hhal 13 22/22 LIS H 14 Hhal
95.2 20) 12 21/21 LISH13 Hhal 14 21/21 FrHl Hhal
95.5 21) 12 21/21 LISH13 Hhal 15 23/23 FrH2 Hhal
92.7 19) 12 21/21 LISH13 Hhal 16 20/20 FrH3 Hhal
97.6 20) 12 21/21 LIS H13 Hhal 17 20/20 FrH4 Hhal
95.0 19) 12 21/21 LIS H13 Hhal 18 19/19 FrH5 Hhal
93.0 20) 13 22/22 LIS HI4 Hhal 14 21/21 Fr HI Hhal
93.3 21) 13 22/22 LISHI4 Hhal 15 23/23 Fr H2 Hhal
90.5 19) 13 22/22 L1SH14 Hhal 16 20/20 Fr H3 Hhal
95.2 20) 13 22/22 LISH14 Hhal 17 20/20 Fr H4 Hhal
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Sim.
Coeff (M) Tk. Pts Organism Enzyme Tk. Pts Organism Enzyme
92.7(19) 13 22/22 LIS H 14 Hhal 18 19/19 FrH5 Hhal
95.5 (21) 14 21/21 FrHl Hhal 15 23/23 FrH2 Hhal
97.6 (20) 14 21/21 FrHl Hhal 16 20/20 FrH3 Hhal
97.6 (20) 14 21/21 FrHl Hhal 17 20/20 FrH4 Hhal
95.0(19) 14 21/21 FrHl Hhal 18 19/19 FrH5 Hhal
93.0 (20) 15 23/23 FrH2 Hhal 16 20/20 Fr H3 Hhal
93.0(20) 15 23/23 Fr H2 Hhal 17 20/20 FrH4 Hhal
90.5(19) 15 23/23 Fr H2 Hhal 18 19/19 FrH5 Hhal
95.0(19) 16 20/20 FrH3 Hhal 17 20/20 FrH4 Hhal
97.4(19) 16 20/20 FrH3 Hhal 18 19/19 FrH5 Hhal
97.4 (19) 17 20/20 FrH4 Hhal 18 19/19 Fr H5 Hhal
171 pairs found
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